Category: Health

  • Stephen Leeder. Telling the story of mental health.

    It is unusual for Foreign Affairs, a magazine published by the United States Council on Foreign Relations in New York, to contain articles on health, but the first issue of 2015 carries an essay (Darkness invisible: the hidden global costs of mental illness) by three distinguished scientists from the National Institute of Mental Health about the hidden costs of mental health.1 Based on evidence from a 2010 Harvard University study on the current and future burden of disease,2 they state that “the direct economic effects of mental illness (such as spending on care) and the indirect effects (such as lost productivity) already cost the global economy around $2.5 trillion a year”, an amount projected to rise by 2030 “to around $6 trillion, in constant dollars — more than heart disease and more than cancer, diabetes, and respiratory diseases combined”.1

    The World Health Organization estimated in 2012 that about a quarter of all time lost to disability is due to mental illness, putting it at the top of the league chart.3 Unlike many other chronic illnesses, mental illness frequently strikes the young. Further, of the 800 000 people who commit suicide each year, 75% are in low-income and middle-income countries.4

    Extraordinary failure

    Yet, the authors of “Darkness invisible” say, the 2010 Harvard report had no impact. In wealthy countries, mental illness is still perceived as an individual or family problem rather than “as a policy challenge with significant economic and political implications”. In many low-income and middle-income countries mental care for the mentally ill is seen as an unaffordable luxury.1 The authors also point to breakthroughs in therapy, especially new medications and the capacity to communicate using mobile phones, that are now more affordable, yet are frequently overlooked.1

    So what are we doing? Globally we are spending around $2 a year per individual on mental health, averaging about 25 cents per person in low-income countries. In Australia in 2004–2005 the average national per capita expenditure on mental health services was $117.5 As we have seen in Australia, the advantages of dismantling mental hospitals that “once oversaw care for the mentally ill”,1 especially those with long-standing severe illness, are accompanied by failures to provide community care for these people. The criminal justice system comes into play by default, in both the acute and long-term management of people with mental illness. In the United States, “30 percent of the country’s chronically homeless and more than 20 percent of the people incarcerated … suffer from a mental disorder”.1 The scene is dismal in Australia as well.

    Darkness invisible explores new technologies including using the Internet and mobile devices to provide psychotherapeutic interventions supported by inexpensive generic medications that could be administered by health workers in the vast tracts of the earth where there are very few medical practitioners and no psychiatrists. The authors may well have wondered about the lethargy among the medical profession worldwide in creating opportunities for the training and deployment of more psychiatrists. We don’t look good as we pass this mirror. There is no substance to our defence when wealthy communities are well supplied with psychiatrists and psychologists.

    A call for better advocacy

    Darkness invisible concludes with a call for mental health advocates to multiply their efforts and “do a better job of explaining to officials and the public the true costs of mental illness”, and “win more allies within the medical profession by drawing attention to the fact that improved mental health leads to better overall health”.1

    This call will resonate with those who perceive the lamentable consequences of unexplained political propositions and proposals: bankrupt policy replaced by sound bites and slogans. There’s a powerful story to be told about mental health, with chapters on the consequences of inadequate care on individual wellbeing and the national economy.

    As a senior business executive put it to me recently, “To succeed, first you must have a convincing story, then good leadership, then the metrics”. More light, more storytelling please.

    Stephen Leeder is Editor in Chief of the Medical Journal of Australia. This article appears in the current issue of the journal.

  • John Menadue. Health Insurance – here we go again!

    The Health Minister, Sussan Ley has just announced a 6.2% increase in private health insurance premiums.  Increases of this order happen almost every year.

    Since the Howard government introduced the rebate on private health insurance in 1999, the cost of private health insurance has increased over 150%. Overall prices have increased by less than 50% in this period.

    Because private health insurance has not got the will or ability to control prices, it is a ‘price taker’ as economists say, it underwrites large increases in health costs particularly by private specialists. That is why we are all paying more in out-of-pocket expenses. But it is even much worse than that. Private health insurance makes it more difficult for Medicare to control fees.

    The private health insurance industry receives a $7 billion p.a. subsidy from taxpayers. This subsidy is far more than the car industry ever received. This is real corporate and middle class welfare. Abolition of the subsidy and at the same time funding a Medicare dental scheme would greatly improve equity and quality of care at no extra cost to the budget.

    Abolition of the subsidy would also remove the Damocles sword that hangs over Medicare. Private health insurance has proven disastrous in the US. We must stop sleep-walking down a similar path in Australia.

    Private Healthcare Australia runs a quite dishonest campaign. Private health insurance has not taken pressure off public hospitals. By funding excessive private specialist fees, private health insurance has attracted many specialists away from public hospitals. Comparing like with like, private and public hospital costs are about the same. The administrative costs of private health insurance are three times those of Medicare.

    But subsidised private health insurance has one particular attraction. It enables wealthy people to avoid the queue for public hospital beds.

    A major beneficiary of private health insurance has been private hospitals and one hospital group in particular. That group is Ramsay Healthcare which operates 120 odd hospital and day-care surgeries in Australia and offshore. Like other supporters of private health insurance, Ramsay Healthcare seldom argues its case publicly. It knows that its case will not stand up to public scrutiny.

    Instead, Ramsay Healthcare relies on lobbying and political influence like so many other wealthy companies and people in Australia. In the last 14 years, Ramsay Healthcare and Paul Ramsay Holdings gave more than $1.8 million to the Liberal Party. Not a cent was given to the Labor Party. Paul Ramsay left an estate of over $3.4 billion recently. Before his death, he was Australia’s eleventh richest person.

    The private health insurance industry relies on lobbying and political influence and not on a publicly defensible case.

    The interests of Australian taxpayers and the Australian community would be better served if the $7 billion taxpayer subsidy was abolished and the money transferred to a Medicare dental scheme.

    The response of the ALP to the latest round of PHI premium increases shows that it has little idea of what is at stake…. Medicare

    See earlier post that I have made on this subject below:

    Two days before Christmas and to avoid scrutiny, the hard-to-notice Federal Minister for Health, Peter Dutton, announced a 6.2% increase in health insurance premiums for next year.

    We have seen the same pattern year after year with health insurance premiums increasing at well ahead of the CPI.

    The Howard Government introduced the Private Health Insurance (PHI) rebate in 1999. Since then the average health insurance premium has risen by 130% while overall prices have risen by less than 50%.

    The Chief Executive of NIB put the reason for the latest increase very bluntly. He said ‘the rise was necessary to meet the rising cost of providing health care’. But PHI is a key part of the problem of rising health care costs because PHI funds have little or no power in the market to contain costs. They are price-takers. The power to set prices in the health market is with the providers – doctors and hospitals – and only a single payer or national insurer, as in the UK or Scandinavian countries with national insurers, can and do exercise market power.

    Medicare would have more market power to control prices if it was the only single payer. But its power is eroded by the PHI companies. A clear example of this is gap insurance which the PHI funds offer. This gap insurance has underwritten the largest increase in specialist fees in Australia in the last quarter of a century.

    If Australians want to waste their money on expensive PHI that is their choice. But I see no reason for taxpayers providing an annual subsidy of $7 billion for PHI that enables the wealthy to jump the hospital queue.

    In February 10, 2013 year, I wrote about the rising cost of PHI. See repost below. I have also reposted ‘Health care and the budget deficit in the US’ which shows the enormous damage that PHI has wrought in the US.

    Repost (from February 10, 2013)

    Last week Health Minister Plibersek approved an average increase of 5.6% in private health insurance premiums from April this year. It is the same story year after year with health insurance premiums increasing at 2% to 3% ahead of the rate of inflation.

    There are two main reasons for these increases.

    The first and least important reason is that the administrative costs of private health insurance companies run at about 15% to 16% of premiums. Medicare, including the cost of tax collection, costs about 6% per year. Broadly speaking private health insurance administrative costs, including profit margin, run at about three times the administration costs of Medicare.

    The second and most important reason for the steady increases in premiums is that private health insurance funds are largely unable to control the price, quality and utilisation of services provided by doctors and hospitals. This is a problem for all insurers, both private and public, when services are provided free at the point of delivery. There is little incentive or opportunity for consumers to exercise power either over  the cost of the service or whether the service is  necessary. The power is with the provider, not the consumer. Economists call this ‘moral hazard’.

    But when a country has a single payer or a single national insurer, as in the UK or Scandinavian countries, the national insurers can and do exercise market power. That is why health services in those countries is invariably delivered efficiently and at low cost. . Private health insurance has practically no power to control prices and demand for health services. What is worse, private health insurance in Australia undermines the ability of Medicare to exercise market power.

    Evidence on the failure of private health insurance is clear. First, the standard example of private health insurance failure is the high cost and inequity of the US health service. That service provides the worst value for money of any health ‘system’ in the world. Secondly, The Economist, in an article on February 18, 2010, said ‘The biggest factor behind the cost conundrum is that insurers lack market power. Health care providers hold all the cards.’  Thirdly, our Productivity Commission said in 2005 ‘increased levels of private health insurance membership have been associated with a marked increase in the number of services performed and reimbursement for those services”.  Fourthly, in a review in 2003 of private health insurance in Australia, the OECD commented ‘Private (insurance) funds have not effectively engaged in cost controls. They seem to have limited tools and few incentives to promote cost efficient care … Private health insurance appears to have led to an overall increase in health utilisation in Australia …’

    Increases in private health insurance premiums ahead of the inflation rate are not surprising. Private health insurance is badly serving Australians and undermines the power of Medicare as a single payer.

    This is not to say that Medicare should not be improved. It is a very efficient payments vehicle. But it is much too passive. It was launched and still carries in its name, the ‘Health Insurance Commission’. If it were a proactive public health insurer, it could significantly reduce the malign influence of private health insurance in Australia.

    See also article by John Menadue and Ian McAuley ‘Private Health Insurance: high in cost and low in equity’ – reposted today below.

     

  • John Menadue. How vested interests are subverting the public interest.

    There are many key public issues that we must address. They include climate change, growing inequality, tax avoidance, budget repair, an ageing population, lifting our productivity and our treatment of asylum seekers.

    But our capacity to address these hard issues is becoming very difficult because of the ability of vested interests with their lobbying power to influence governments in a quite dis- proportionate way.

    Lobbying has grown dramatically in recent years, particularly in Canberra. It now represents a growing and serious corruption of good governance and the development of sound public policy. In referring to the so called ‘public debate’ on climate change, Professor Ross Garnaut highlighted the ‘diabolical problem’ that vested interests brought to bear on public discussion on climate change.

    These problems include:

    • There are over 900 full time independent lobbyists working in Canberra, more than 30 lobbyists for every Cabinet minister. On top of these ‘third party’ lobbyists, there are the special interests who conduct their own lobbying, such as the Australian Pharmacy Guild.
    • These lobbyists encompass a range of interests including mining, clubs, hospitals, private health funds, business and hotels that have all successfully challenged government policy and the public interest. Just think what the Minerals Council of Australia did to subvert public discussion on the Super Profits Tax and the activities of Clubs Australia to thwart gambling reform, or the polluters over an Emissions Trading Scheme and the Carbon Tax. With its lobbying power over the major parties, the hotel lobby at the State level effectively determines hotel operating hours. Violence and crime are a result.
    • With journalism under-resourced, the media depends increasingly on the propaganda and promotion put into the public arena by these vested interests The Australian Centre for Independent Journalism at UTS found in a survey of major metropolitan newspapers published in Australia in 2010 that 55 per cent of content was driven by public relations handouts from lobbyists and their associated public relations arms, and 24 per cent of the content of those metropolitan newspapers had no significant journalistic input whatsoever., relying heavily on public relations handouts.
    • The Media Council of Australia has drawn attention to how media independence is increasingly compromised by ‘advertorials’, a deliberate confusing of advertising and editorial content. The Council also drew attention to trips financed by large corporations and organisations that were not disclosed. It’s not just travel companies that do this.
    • With over 60 per cent of metropolitan newspaper circulations in Australia, News Ltd is a major obstacle to informed debate on key public issues like climate change.
    • The health ‘debate’ is really between the Minister and the Australian Medical Association, the Australian Pharmacy Guild, Medicines Australia and the Private Health Insurance companies. The debate is not with the public about health policy and strategy, it is about how the Minister and the department manage the vested interests.
    • The wealthy private schools are obstacles to needs based funding which is necessary for both equity and efficiency reasons
    • Much of the policy skills in Canberra departments has been downgraded and much of the policy work is now in the hands of young staff in ministers’ offices that are much more inclined to listen to vested interests.
    • Policy work within the government is now undertaken more in specialist organisations such as the Productivity Commission rather than in the departments. Departmental policy capability has been seriously denuded.

    What can be done?

    • Federal lobbyists have to be registered with the Department of Prime Minister and Cabinet, but this is inadequate. They should also be obliged to promptly, publicly and accurately disclose the discussions and meetings they have had with ministers, shadow ministers and senior public servants.
    • All proposals by special interest groups should be accompanied by a public interest impact statement prepared by an independent and professional body. This public impact statement would be attached to representations from the vested interest group. Many of the major private consulting firms should be excluded from this process as many of them have shown themselves to be compromised in the interests of their clients.
    • Refuse tax benefits for ‘think tanks’ like Institute of Public Affairs which are secretly funded and act as fronts for vested interests.
    • Departments such as Health which are so influenced by special interests should have different governance arrangements. The traditional minister/departmental model in Health is a happy hunting ground for vested interests that significantly influence outcomes in health. The Reserve Bank, composed of independent and professional persons, has shown the benefit of such governance arrangements in keeping vested interests at bay and promoting an informed public debate. We need such an arrangement in the health field particularly.
    • No minister or senior official should work with a vested interest group that they have been associated with for at least five years after retirement or resignation.
    • There should be increased funding to the Parliament to provide alternate public advice in key policy areas. The Parliamentary Budget Office is a good start. The current policy vacuum must be filled by independent and professional advisers. At the moment the policy vacuum is filled by special interests assisted in many cases by a compliant and under-resourced media.
    • Adequate funding of the Australian Broadcasting Commission to assert the public interest and develop good public policy is now more important than ever.
    • Major reform of election funding to stop powerful groups buying political favours.
    • A federal Independent Commission Against Corruption and in each State to examine allegations of corruption.
    • Citizen Assemblies of randomly selected people who are fully informed on key public issues to advise governments.

    Action to assert the public interest in the face of powerful vested interests is necessary on many fronts. The problem is urgent.

    This article is part of a series ‘Who speaks for and protects the public interest in Australia? published by Australia 21. Other articles in this series can be accessed by clicking on my website at the top of this page.

  • John Menadue. Cover-up in the health system.

    There is an unacceptable refusal by many in the health sector to publish data and information about how services are delivered. There is a cover-up by powerful providers who don’t want transparency and exposure about the way they work.

    At the Bundaberg Hospital some years ago it was clear that surgeons had little confidence in surgeon, Jayant Patel. But they sat on their hands and did little to protect the public. It was left to nurses to blow the whistle and risk their careers.

    Judge Geoffrey Davies AO spoke of this problem in an address last October to 1,200 orthopaedic surgeons in Brisbane. The speech was reported earlier in this blog (7/12/15). It is very blunt about the performance of many orthopaedic surgeons.

    Extracts from the transcript of his speech follow:

     

    Why won’t you do something about incompetent surgeons?

    The Hon Geoffrey Davies AO

    You all know that, in your midst, there are incompetent surgeons; surgeons whom you would never recommend to your friends or family. They may have varying degrees of incompetence and for different reasons. But all are a danger. All can cause injury.

    Together you know who many of them are. But for various reasons you have done little individually and nothing collectively, to expose them or even to identify them confidentially for the purpose of retraining or limitation of practice.

    Patients are entitled to know, before they choose you for their surgery, rather than one of your competitors, not only how your fees compare with those of your competitors, but also how your success rate compares with that of your competitors; and that that latter information, in the case of much orthopaedic surgery, is recorded in your National Joint Replacement Registry.

    Why would surgeons who are otherwise honest and decent men and women and who are themselves competent, fail to speak out against what was plainly gross incompetence causing harm? The author of the Bristol Inquiry report described it as an “old boys’ culture”. But that is simply a euphemism. The true reason must surely be either a view that the reputation of your profession is more important than the health and safety of patients; or a view that the incompetence of your colleagues is none of your business. It can’t surely be a misplaced loyalty to your incompetent colleagues. It wasn’t in Bundaberg because none of the other doctors there really liked Dr Patel.

    If, individually, you don’t speak out, patients may be injured, possibly seriously.

    As you are aware, following my Inquiry, there is now a mandatory requirement that you notify the Health Ombudsman if you have a reasonable belief that another health professional has behaved in a way which constitutes a significant departure from accepted professional standards; and that such behaviour has placed the public at risk of harm. You do not appear to have responded to this obligation notwithstanding the freedom which it confers from any legal or administrative action. And the legislation invites you to notify in respect of less serious incompetence and, if you do, also offers you full protection against legal or administrative action provided your notification is made honestly.

    If, in those circumstances, you as individual surgeons will not act to protect the public from your incompetent colleagues, I have come to wonder how likely it is that your association or any other specialist association is ever likely to do so. However, as I shall point out, there are a number of ways in which it can and should do so.

    Surgeons who are the subject of multiple complaints Studies in 2006 in New Zealand and the United Kingdom both show a close correlation between complaints and preventable adverse events :

    -Two thirds of complainants had experienced adverse events; and
    -75% of those adverse events were preventable.

    And a study in 2012 of nearly 19,000 formal health care complaints against doctors, including surgeons, in Australia between 2000 and 2011 showed that two prior complaints over eleven years was a strong predictor of short term further complaints. It found that:

    – compared with doctors with one prior complaint over that period, those with two complaints had nearly double the risk of recurrence;
    – that risk increased substantially with each additional complaint.
    – and these, in turn, showed that complaint prone doctors could be identified early in their complaints trajectory.

    Together these studies show, in my view, a strong likelihood that those surgeons who have had, for example, two or more complaints within an eleven year period are incompetent.

    Evidence (also) show that incompetent surgeons are much more likely to be found among older surgeons than among surgeons in early or mid-career.

    There are three conclusions that can be reached from this evidence. The first is that the proportion of incompetent surgeons is likely to be greater in the older age group than in the mid-career group. The second is that this conclusion is not generally recognised or, at least, admitted within your profession. And the third is that there needs to be much greater scrutiny, than there is at present, of the performance of older surgeons, partly for these reasons, but partly also because there is likely to be much greater resistance, in your profession, to complaining about a once competent surgeon who is no longer so than there is about a younger incompetent surgeon.

    Individual notifications under the Legislation, like complaints by patients, can never uncover more than a small percentage of the total number of incompetent surgeons. That is why the primary responsibility for uncovering and dealing with incompetent surgeons must be upon those who can establish a system for such objective assessment.

    The view that the best way of determining competence is by assessment of actual operations appears to be rejected by you in a number of ways.

    First, you appear to ignore the fact that multiple complaints against a surgeon probably prove a pattern of incompetence.

    Secondly, you will not make participation in morbidity audits compulsory notwithstanding the overwhelming evidence of the benefit of such participation.

    Thirdly, you will not permit audits of either kind to identify and record the name of a surgeon the subject of adverse events notwithstanding the evidence that this would enable determination of a pattern of incompetence.

    And fourthly, you will not permit the NJRR to be used for this purpose notwithstanding that, as I believe, it can do so. If I am correct in that belief, I think that you have been acting improperly in failing to use it for that purpose. In saying that I appreciate that surgeons have been contributing data to the NJRR on the promise of anonymity. But that could and should have been changed before now.

    I cannot see how the imposition of a fine or suspension from practice for a period can, alone, be an appropriate remedy for incompetence. The surgeon should be retrained if that is possible. But in many cases, especially those of older surgeons, that will not be possible. In that case he must have his practice limited to exclude operations of the kind which he cannot safely perform or he must be prevented from practising. Suspension from practice, in whole or in part, is appropriate only while decisions are pending about retraining or limitation or ceasing practice.

    Why you won’t do something about incompetent surgeons?

    I regret to say that my answer to this question is not one which you will like. Yet all of the evidence that I have seen convinces me that I am right.

    What then is the answer to my question? I think that there are two.

    The first involves how you think and act individually.

    Many of you are concerned that disclosure of your own success rate or, more accurately, your failure rate might increase your risk of being sued. But realistically that is a risk for only a small minority whom you should want to see dealt with, for the health and safety of future patients.

    Many of you are also concerned that reporting another surgeon whom you believe is incompetent may rebound on you. I have said that I understand that. But that concern does not excuse you, particularly given the protection which the law now gives you.

    The second involves how you think and act collectively, as the AOA.

    Collectively you are, it seems to me, still primarily a trade union having the primary purpose of looking after the wellbeing of orthopaedic surgeons. And sadly you appear, so far, to have put that before the health and safety of patients.

    To change that you must make participation in morbidity audits compulsory for your members. You must require the recording of the names of surgeons involved in adverse events. You must use the results of these, and the results of complaints records to identify incompetent surgeons.

    And you must use the NJRR for this purpose.

    When I spoke at your annual conference in Adelaide four years ago I was still optimistic that you might, individually and collectively, do something about this serious problem. Despite your inaction since then, I remain optimistic. But time and public confidence are running out.

     

    Geoffrey Davies was a judge of the Queensland Supreme Court of Appeal for 14 years. He headed the 2005 inquiry into the Bundaberg surgeon Jayant Patel. 

    This speech was reported in The Australian on October 17, 2015.

     

     

     

  • Michael Gracey. Why is closing the aboriginal health gap failing so badly?

    The disparity between the health of Aboriginal people and other Australians first drew wide public attention In the 1960s; it became known as “The Aboriginal Health Problem”. This awareness came from reports of widespread and severe malnutrition in Aboriginal infants and young children, high rates of infections and gut parasites, high infant mortality, and reduced life expectancy.

    This wasn’t good enough for a wealthy nation like Australia, the “Lucky Country” if you like, where the luck seemed to not extend to the First Australians. There was a public outcry at the time, followed by almost predictable political reactions aimed at correcting the inequity.

    Strategies were devised, programs planned, health professionals were employed, and huge sums of taxpayers’ dollars were allocated and spent over the next half century. So we are entitled to ask “what happened?”

    There were some gains. Aboriginal infant mortality rates fell, their average birth weights increased, rates of malnutrition dropped, vaccine-preventable infections receded, rates of severe child infections declined and deaths from childhood gastroenteritis plummeted. These encouraging improvements were mostly due to conventional public health measures including childhood vaccination, better hygiene, and earlier referral for treatment of illnesses, greatly improved treatment for childhood diarrhoea and dehydration, and employment of skilled clinical personnel. But over the past thirty or so years many aspects of the health of Indigenous people have deteriorated. Why?

    Since the 1970s there have been substantial changes in the living patterns of Aboriginal Australians, particularly in rural and remote areas. Political, legal and administrative changes occurred from the late 1960s that had profound effects on Aboriginal people and communities. Examples include the introduction of equal pay for equal work, the granting of drinking rights to Indigenous persons, various systems of welfare support and payments, increased reliance on the welfare system, and a rapid shift from traditional lifestyles to that of a typical Westernised contemporary society. This all occurred on an entrenched system where Indigenous people were disadvantaged in almost all aspects of their lives from the rest of the wider Australian society.

    Indigenous people went through a swift lifestyle shift and became less physically active, more sedentary, and consumed modern foods and drinks that were more calorie-dense, contained much more fat and salt and less fibre than in previous times. The stage was being prepared for a tidal wave of chronic so-called “lifestyle” diseases which threatened their survival. The Tsunami of obesity, diabetes, high blood pressure, heart disease, stroke, chronic kidney disease and renal failure descended on them with a vengeance. Not only that, the stresses associated with maladjustment to these changes, socio-political disadvantage, under-education, unemployment and racial prejudice combined to make them a sub-group that was vulnerable to a heavy burden of disease, disability and excessively high mortality.

    However, increasing numbers of Indigenous Australians are not trapped in this unfavourable vortex of negative factors. Many are being well-educated, achieving high levels of competence and success in their daily lives, in business, the professions, and academia, and are becoming leaders in Australian society. These people provide encouragement towards future successes and recognition of Indigenous people as exemplars.

    But the negative impacts of various factors on the health statistics of Indigenous people over the past 30 years are a cause for serious concern.

    The persisting, yawning divide between the health statistics of Aboriginal people and other Australians has become known as “The Aboriginal Health Gap” which is one of this country’s worst embarrassments. In 2008 the then Labor government committed to “close the gap”, a phrase which in my view has been overstated. That commitment was to make the health, disease and death statistics, as well as other markers of Aboriginal well-being, match those of other Australians by the year 2030. This is not achievable. Apart from the vast discrepancies that are so entrenched in the lives of most Indigenous Australians, such as poor educational standards, high unemployment, lower per capita incomes, and unsatisfactory housing and access to services, there are many biological factors that contribute to ill-health that have strong components that persist for more than one generation. This means that issues that affect future generations, such as the health and nutrition of pregnant Aboriginal women and breast-feeding mothers, must be corrected before improvements can occur for the following generation or more. This simply cannot be done within 20 or 30 years. Similarly, the heavy chronic disease burden of, for example, diabetes and its long-term complications, chronic kidney disease and kidney failure that are so prevalent in young Aboriginal people, cannot be fully eliminated within one generation.

    Reviewing the official annual reports about progress over the past seven years is a disheartening exercise. Many of the stated targets have not been reached and, in some areas, things have deteriorated despite the immense amounts of public funds which have been used in “close the gap” programs. This was admitted in February 2015 by the Prime Minister when commenting on the seventh annual report; senior Indigenous spokespersons agreed that the findings were very disappointing. What’s gone wrong?

    Looking objectively at the situation it must be admitted that the federal government commitment in 2008 was: (a) well-intentioned; (b) ill-informed; (c) not adequately thought through; (d) bureaucratically top-heavy and clumsy; (e) naïvely optimistic; (f) culturally insensitive; (g) rhetorical rather than realistic; and (h) ignored the biological restrictions imposed by previous generations on altering health outcomes in subsequent generations of children.

    Why shouldn’t the government admit that the commitment made in 2008 was not feasible and start again? A serious problem with a failing program is that many people feel let down, disheartened and frustrated because the expectations are not being realised. This is particularly so for those who have the most to gain or lose – the Indigenous people. This won’t change until a more realistic strategy and timetable are devised, perhaps with a new name.

    Government must accept that approaches used over the past 30 years or so have, with few exceptions, like those already mentioned, not worked. This applies to different levels of service delivery; government, the private sector, and Aboriginal-controlled medical services.

    A fresh approach is needed. To date governments have given little encouragement to Indigenous people to become agents of change for their own health. Community engagement, commitment, and acceptance of responsibility must occur at the local level if real change is to be achieved. This will provide opportunities, previously denied to Indigenous communities and their members, to learn at first-hand: (1) the determinants of health; (2) what causes illness; (3) how diseases can be prevented; and (4) how health service systems operate and can be modified as required. Community involvement in these matters will provide, perhaps for the first time, a new deal with local people being real partners in programs to improve their own health. This will require collaborative teams with long experience in health and health services, community development, cross-cultural knowledge, empathy, patience, and inter-personal skills to work in small groups around Australia. This strategy uses a previously untapped resource, local Indigenous people and communities, to help “close the gap”. Governments will have to commit to radical changes in order to achieve this.

    Meanwhile, all the other social, economic and environmental factors that affect health outcomes will need to be addressed vigorously. Without such changes, for example in education and employment opportunities, the failures of the past will continue.

    Michael Gracey AO MD PhD FRACP FAAP

    Professor Gracey is a paediatrician who has worked with Aboriginal people, families, communities and organisations for more than 40 years. He was Principal Medical Adviser on Aboriginal Health in the West Australian Department of Health and was Australia’s first Professor of Aboriginal Health. He has also served as President of the International Paediatric Association.

  • Mary Chiarella. Luke Foley – Nurse-led clinics and primary health care.

    In 2011 I gave the last Oration for what was originally the NSW College of Nursing in the Great Hall of Sydney University. In it I advocated for nurses to be able to work to full scope of practice, particularly in the area of primary and preventive health care, in order to alleviate demands on our overstretched hospital systems. Given we currently have a significant oversupply of nurses in this country, especially in our new graduate population, this seems like an excellent time to deploy nurses into some of these roles, long overdue in Australia but commonplace in other parts of the world. . The first ever NSW College of Nursing Oration was given on the 15th September 1953 by M.I. Lambie, who was not only the first Orator for the College, but the first woman to give an Oration in the Great Hall of Australia’s oldest university. Miss Lambie was the New Zealand Nursing Adviser to the World Health Organisation (WHO) and Chair of the Expert Nursing Committee of WHO. Let me read to you her introductory words as she talks of the problems in health care in the developed world:

    These facts have caused increasing demands on hospitals; the rapid turnover in surgical beds together with the larger numbers of elderly and chronic patients has forced consideration to be given to the whole problem of hospitalisation by many authorities. The increased use of hospitals means automatically more staff or the better use of existing staff”[1]. 

    Plus ca change, plus la meme chose. She goes on to advocate for the growth in primary health care that is occurring in developing countries “putting more emphasis on the preventive aspect, which in turn will set an example to many of the older countries”. Well sadly not much yet, Miss Lambie, not much yet. I’m afraid the people you were advising didn’t take your excellent advice. Lots of us have been there.

    She goes on to say

    These are examples whereby preventive means, home education and treatment have reduced the demands for hospital beds. In fact it would not have been possible to treat in this mass way in an institution. The education of the home for this kind of treatment means, however, the preparation of a worker to carry out the program. Funnily we speak of this NEW approach to medicine, and yet in her Notes on Nursing, Florence Nightingale speaks of “the need to nurse the home as well as the family[2]. 

    So we come full circle in what is needed for health care in Australia, advocated by Florence Nightingale in the 19th century, advocated by the first NSW College of Nursing Orator, Miss Lambie in the 20th century, and advocated in the 21st century by the (then) Australian Nursing Federation[3]. Let us hope, in the promises of Luke Foley to introduce four nurse-led clinics in NSW should Labor win the next election, that the wise words of our nursing forebears do not have to wait another 62 years before somebody decides to act on them. This is so obvious a solution that one wonders why it is not commonplace, rather than tentative.

    Mary Chiarella is Professor of Nursing, Sydney Nursing School, University of Sydney.

    [1] Lambie IM (1953) First Annual Oration The changing scene in health work throughout the world in The 50th Anniversary Annual Orations Vol I NSW College of Nursing: Sydney, p.9

    [2]  Ibid, p.10

    [3] Australian Nursing Federation (2009) Primary health care in Australia: a nursing and midwifery consensus view ANF: Canberra

  • Jill White. Nurse Led Clinics for NSW.

    Luke Foley – great!

    Congratulations on committing to nurse led clinics as part of to a primary health care strategy to increase access to community based health care. The four nurse led clinics promised last week are a welcome adjunct to the current but often overstretched GP services.

    The ACT has led the way in nurse led clinics with the first, based in an emergency department, being evaluated as providing high quality safe and appropriate care; however where there was also easy access to medical care there was the risk of over-servicing lessening the cost effectiveness.  So with lesson learned the two new ACT services are in underserviced areas and are providing high quality care to a population which otherwise would have had difficulty in quick and affordable access to health care. Information on these services is available through ACT Health. It is a success story, ask the people of Belconnen and Tuggeranong.

    Our current NSW Minister for Health, Jillian Skinner, also has a public track record of commitment to improving community based services. So come on Jillian, match this promise and let’s not let party politics and election posturing get in the way of a really good idea for the health of the public.

    The past few weeks has clearly demonstrated that we are heartily sick of party based oppositional politics and if NSW does not want to risk going down the same path as Queensland or suffering the public disenchantment experienced by the Prime Minister this is the moment and this is the issue to demonstrate that the health of the public is a genuine bipartisan concern and that this is an excellent strategy. Let’s make these clinics a reality irrespective of any election and have a public commitment from both sides of politics NOW.

    I can’t let this topic go however without addressing Saxon Smith’s comment on behalf of the AMA in the SMH yesterday. He is quoted as saying “There is actually evidence suggesting nurse-led clinics can make the quality of the care worse”. What research? Conducted how and where and published in what peer reviewed journal? It is a glib and easy thing to say but where is the evidence? How does it stack up against the 20 years of rigorous, published, Australian based research which clearly demonstrates the safety and quality of the work of Nurse Practitioners?

    It’s always worth reminding ourselves  that the AMA is not only a professional body but it is also the doctor’s union and protecting income and turf is its job. We have 25 years of documented AMA opposition and scare tactics about nurses being able to work to their full scope of practice and making a broader contribution to community health.

    The vast majority of doctors in practice with whom I speak fully support an extension of the role of nurses in primary health care/ community care. They particularly understand the need to provide better access to underserved communities. This is work nurses want to do, are educated to do, and have the skills to do. Luke and Jillian please bring it on, make the commitment and don’t let better healthcare become a political football.

    Jill White was formerly the Dean of the Faculty of Nursing and Midwifery at Sydney University. 

  • John Menadue. Fairness, Opportunity and Security – Filling the policy vacuum

    I sense that there is great public concern that both the government and opposition keep playing the political and personal game at the expense of informed public discussion of important policy issues.

    We have become concerned about the trustworthiness of our political, business and media elite. Insiders and vested interests are undermining the public interest. Money is unduly influencing political decisions. There is gridlock on important issues like climate change and taxation.

    After a near death experience Tony Abbott has said the he is open to new thinking and ways of governing. ‘Good government begins today’  Time will tell. Bill Shorten has said that 2015 will be the year of ideas. I hope so.

    In this blog over the next few months I will be posting a series of articles on important policy issues. I posted a three parter on health policy on January 27, 28 and 29.

    There will be range of contributors.Some  have contributed in the past to this blog

    Each of the policy articles will be about 2000 words. They will not be “pie in the sky’ but realistic, given our political and financial constraints.

    It is planned that these policy articles will be published in a book by ATF Press in October/November this year

    Policy areas to be canvassed

    Economic policy

    Fixing the budget

    Taxation

    Federalism

    Productivity

    Job creation and participation

    Foreign policy

    Security, both military and soft power.

    Health

     Development of our human capital in the fields of education, science, research and development and innovation.

    Transport and infrastructure

    Population/migration/refugees

    Welfare priorities

    Retirement incomes

    Indigenous affairs

    Communications and the Arts

    Environment and climate change

    Inequality

    Role of government including tackling corruption and bad behaviour

    Democratic renewal – the lack of trust in government and the hollowing out of our political parties.

    Terrorism and internal security whilst protecting of our freedoms

     

  • John Attia, John Duggan. Why the government would have us pay more for poorer health.

    The Coalition government has been claiming that Australia’s public health system is unsustainable since the 2014 budget. But its plans for the health system actually reflect the underlying belief that user-pays health systems are better – despite evidence to the contrary.

    Less than a year and a half into the Abbott government’s first term, we’re on our second health minister and the third iteration of some kind of plan to introduce a co-payment for seeing a doctor. Despite widespread and vocal opposition to its plans, the government remains committed to introducing this price signal into the public health system.

    Underpinning this move is the government’s commitment to a user-pays health system. But there’s now a large body of evidence showing such systems not necessarily great for the nation’s health. Here are four common ideas about market-based health systems and why they are not true.

    Myth one: market forces increase efficiency

    The administrative costs of Australia’s public health system are considerably lower than that of the private health insurance sector. So while this cost for Medicare is around 6% per year, the 2012-13 private health insurers’ annual report estimates that 15% to 18% of private health insurance premiums go towards administration.

    Both these figures are similar to those in the United States, the country with the most expensive health-care system in the world. Figures from the OECD estimate that, in 2011, the per capita health cost in the US was US$8,508 (A$10,912) per head or 17.7% of GDP, compared to Australia, where the figure was US$3,800 (A$4,875) per head or 8.9% of GDP.

    But the US figure quoted above is effectively still an underestimate. The premiums for about half the Americans who have health insurance are paid by their employer; they are essentially a business deduction underwritten by the taxpayer.

    The inefficiencies of the market-based system are also apparent when comparing costs for similar conditions. Health insurance industry figures from a 2013 report show the average total reimbursement for a private hospital appendectomy in the United States is A$17,770 (US$13,851), while the cost for the same procedure in Australia is A$5,467.

    Both the former and current Coalition health ministers – Peter Dutton and Sussan Ley – have insisted on introducing a price signal for GP visits. Gary Schafer/Alan Porritt

    Myth two: market forces increase quality

    There’s no lack of evidence showing the market forces operating par excellence in the United States offer inferior health care when compared with public health systems. OECD data comparing mortality rates in member countries between 1980 and 2005, for instance, show only Portugal has had a smaller fall in adult mortality rates than the United States.

    And although it spends the highest proportion of GDP on health internationally, the United States ranks 19th in infant mortality, 43rd in female mortality and 36th for life expectancy.

    This is not to say that US health care cannot be outstanding; it just comes at a price rendering it grossly inequitable. Consider this 2008 study of 121,092 Americans admitted to hospital with bleeding from liver cirrhosis. It found likelihood of death was significantly higher for certain groups.

    By contrast, a 2011 English study of gastric bleeding in 245,438 patients found that, once hospitalised, the risk of bleeding and mortality was independent of social class. So in England, an unemployed street sweeper with gastric bleeding faces a similar risk of death in hospital as a stockbroker. But the stockbroker would have a much better outcome in the United States.

    It’s also important to remember that more care does not necessarily equate to better quality care. The Institute of Medicine recently estimated the excessive annual cost of systemic waste in the US health-care system at US$765 billion. This is almost 30% of total health expenditures.

    Over-servicing is a big problem in private health-care systems, where profits can create a perverse incentive to treat. Indeed, they potentially create a conflict with purely medical reasons for treatment.

    A landmark 1970 analysis (not available online) comparing surgery and surgeons in the United States and in England and Wales showed that the former, with its fee-for-service system, had twice as many surgical procedures as the latter places, both of which have public health systems. A 1973 analysis found a similar doubling of discretionary surgical rates in fee-for-service Canada compared to the United Kingdom.

    Myth three: public health care is unaffordable

    A number of studies indicate that it is actually private health care that’s unaffordable. It’s estimated that almost two million people in the United States declared bankruptcy due to medical bills or conditions in 2013.

    Despite widespread and vocal opposition to its plans, the government remains committed to a price signal for GP visits.NEWZULU/PETER BOYLE

    That makes health care one of the biggest issues affecting bankruptcy in that country. Worse still, the majority of these bankruptcies were expected to affect people in the prime of their working lives, between the ages of 35 and 55.

    Worse still, the problem may be snowballing: a 2009 study found medical reasons for bankruptcies had increased from 46.2% in 2001 to 69.1% in 2007. Most medical debtors were well educated, owned homes and had middle-class occupations, and 75% had health insurance.

    Despite the Coalition government’s warnings to the contrary, health-care costs are not spiralling out of control. According to an Australian Institute of Health and Welfare report on health spending for 2012-13, growth in health expenditure was the lowest since the mid-1980s.

    In fact, the average health expenditure per person fell from A$6,447 in 2011-12 to A$6,430 in 2012-13. This puts Australia’s health spending as a proportion of gross domestic product at 9.4% in 2012, just above the OECD average of 9.2% – and much lower than the cost of the US market-based system.

    Myth four: price signals work

    Indeed, the government’s commitment to price signals is itself rather problematic. Price signals temper consumption by making people consider whether what they are about to buy is worth the cost. This makes them ill-fitted to the health-care sector, which is not an optional commodity subject to the same thinking that influences decisions to buy a television or a pizza.

    The latest evidence about co-payments comes from the introduction of the 2005 Deficit Reduction Act in the United States, which allowed states to introduce emergency department co-payments for non-urgent visits. A very recently published analysis of figures from eight states that charged a co-payment and ten states that didn’t showed no difference in annual number of emergency department admissions, visits, or inpatient days.

    Evidence to date is overwhelmingly against the privatisation of medicine. By pulling together in a public system, citizens get better value and the government gets better outcomes.

    Along with education, health is a basic pillar of a just society. It represents government investment in the country’s social capital – its people. Failing to provide these adequately and equitably will reduce Australia’s productivity, competitiveness and, in the end, the sense of social cohesion that comes from equal access and equal opportunity.

    John Attia is Professor of Medicine and Clinical Epidemiology at University of Newcastle.  John Duggan is Conjoint Professor at University of Newcastle. This article first appeared in The Conversation, 5 February 2015.

  • John Dwyer. Health Policy Reform Commentary – Part 2

    In the first part of my commentary on John Menadue’s Health Policy Reform in his blog, I discussed  the barriers frustrating any reform agenda. In this second part I will comment on John Menadue’s suggestions for “overcoming these obstacles to health reform” and provide my own thoughts on what a reformed health system might look like.

     

    In his blog he commented that “seldom do we stand back and ask the central issue: what do we need and expect from a health system”? For some years now I have presented the following answer to that question to professional and community audiences. We need, deserve and can afford a health system that—-

    Is focused on the needs of the individual, is resourced to maximise opportunities for avoiding illness (prevention), is demonstrably equitable, sustainable and provides evidence based quality care in a timely manner available on the basis of need not personal financial wellbeing”.

    A few years ago, thanks to an initiative of the Division of Primary Care at the University of Queensland, I had the opportunity to take part in a series of town meetings around Australia where we discussed what citizens wanted from their Health Care system. We dissected the elements of the above definition and each of the elements therein was readily appreciated and endorsed. The concept of a “medical home”, (recently discussed in Pearls and Irritations) as provided by an Integrated Primary Care model was often greeted with a “Why didn’t we introduce that ten years ago” question. I was interested in the acceptance by audiences that we may need to pay more for a better health system and the willingness to do so.

    I discussed the above definition and its ramification at a national meeting of the Australian Health Care Reform Alliance to which we had invited Tony Abbott, health minister at the time. He told us that he did not like to hear talk of “reform” when we already had the best health system in the world that only needed “a little tinkering at the margins”. I was reminded of this when reading John Menadue’s comment that reform “will be hard without political leadership and political will”. There are none so “non-reformist” as those who insist there is nothing to reform.

    What reforms would provide us with the health system we need and how do we overcome the political inertia? A single funder of our national health scheme remains the “Holy Grail” for most reform commentators. As John Menadue highlights the jurisdictional division of health care such that hospitals are the responsibility of the States while our Federal government funds Primary Care(GP’s and others) is the single largest barrier to both integrated and cost effective (sustainable) care. We are the only OECD country so burdened. Perhaps Federal and State governments think that the cost shifting and “blame game” that follows is politically attractive as the public may be unsure who is responsible for problems. No one is asking the Commonwealth to be the sole provider of health care. Rather we are suggesting that the Federal government fund providers that will, implement the health care model Australians and their government have agreed upon. However while we must not abandon the goal, the current reality is that neither major political party is interested in the single funder model.

    Looking at our needed reforms and learning from the experience of other countries that have modernised their health systems it is not difficult to provide a map for a reform journey.  As is true for any journey one must have a definite destination in mind. The journey may have its trials and tribulations but the destination is set. Our destination (the Health Care system we need and can afford) must be determined by in depth discussions with Australians about the need for change. Readily understood models must be put forward for analysis of their benefits as well as the associated ramifications. This is particularly important if more public expenditure is required to fund the new model.

    Apart from the old-fashioned “Town Hall” style meeting referred to earlier, there are numerous opportunities for providing information to and receiving feedback from the community.  I was most impressed with the quality of the discussions provided by “citizens juries” moderated by the much-missed Gavin Mooney.  All media outlets including social media would be utilised. I agree with John Menadue that the process of consultation and the formulation of the desired model and the elements it contains (our destination) should be overseen by a Health Reform Commission populated by independent professionals and community representatives so that it is demonstrably apolitical. The model must be “efficient and equitable”, efficient in that it provides the clinical outcomes desired in a cost effective manner and equitable in that its benefits are available to all Australians.

    While the longest journey starts with the first step, in this case it is the very first step that is likely to be most difficult. That first step requires us to break through the barrier of political intransigence.  International experience and a study of what I believe we need to do in Australia suggest that our journey will take about a decade to achieve the desired transformation. As John Menadue suggests it cannot be rushed. And there immediately is a political problem as increasingly short-term governments are disinterested in projects without imminent political kudos.

    However if we are ever to achieve political support for reforms we must be able to present a clear vision of what we want. Perhaps the most frustrating part of the present Government’s attacks on primary are is that it is devoid of any vision for improving outcomes and cost effectiveness.

    What follows is a summary of the initiatives and organisation we might see if the community and government were to want our health system to have the characteristics I described above.

    The Health Reform Commission would hand over reform implementation to a new statutory body; say the Australian Health Authority (AHA) and certainly not the Department of Health and Aging. This organisation must take us to our destination. It holds all the health care funds expended by the Commonwealth and States. It replaces nine departments of health. It mangers a series of necessarily central bureaucratic processes, such as the PBS, public health policy and interactions with numerous agencies in order to support the social determinants needed for a healthy community. It establishes a series of Regional Health Authorities (RHAs) dividing Australia into logical and manageable demographic clusters and provides each with funds based on a resource distribution formula that is responsive to local need and not just population numbers.  In this way the current problems created by State boundaries being artificial health boundaries are overcome.

    RHAs would seek providers for Hospital, Community and Primary Care services. The States may well seek funds to continue to manage their hospitals but the role delineation for such hospitals would be negotiated with the RHA. A number of Primary Health Care organisations will be funded in a region. (The current model of having a small number of PHOs replacing Medicare locals and responsible for improving care over huge areas but not actually offering direct care is fatally flawed}.

    Within RHAs Primary Health Organisations would act as hubs in a hub and spoke model directly offering primary and secondary services (In New Zealand they may run 23 hour wards and treat minor emergencies). PHO’s would offer a range of supportive services to affiliated primary care practices. These would include help via bulk purchasing, continue professional development, drug education, and IT management and, crucially, help with required data collection to document health outcomes.

    The preferred model of primary care supported by RHAs would feature the “medical home” model of Integrated Primary Care wherein funding is available to support teams of health professionals (including dentists and dental hygienists) working in the one practice to help enrolled patients with prevention strategies and early diagnosis and management of health problems that could result in chronic illness. In house teams would manage chronic and complex disease and care in the community for many currently sent to hospitals.

    In this model “Fee for Service” (FFS) payments would only be applied to “drop ins’ with short term self-limited problems. (John Menadue  accurately pointed out the perverse incentives attached with FFS payments and certainly young doctors contemplating a career as a GP are turned off by the thought of practicing “turnstile” medicine. (Some movement within the AMA to support a move away from FFS heartens me). Chronic disease management is covered by capitation funding with a bonus system for better health outcomes. A consumer controlled electronic health record facilitates integration of the care offered by all providers and hospitals.

    Best practice management in community and hospital settings is facilitated by the availability of standardised evidence based clinical pathways for a given problem These would be generated by “craft groups”, specialist doctors, nurses and allied health professionals working in a given field who “think globally for action locally”. Professors Kerry Goulston, Graeme Stewart and I set up such a process with excellent outcomes in NSW. The methodology is now applied more broadly by the Agency for Clinical Innovation. This provides a major weapon in the effort to reduce expensive investigations and procedures of little clinical value described in the first part of my commentary.

    In the light of these new directions medical education has to change and inter-professional learning curricula are necessary to prepare the next generation of health professionals for “Team Medicine”. Rural based medical schools with postgraduate specialist training available in rural settings is  necessary to solve the shortage of medical practitioners in rural Australia.

    John Menadue’s forecast that 15 billion dollars could be saved by health system reform is too modest. The above “imaginario” if implemented would save much more. Overseas experience suggests that we could expect a 30-40% reduction in hospital admissions over 10 years. Just before Christmas the UK government received a commissioned report indicating that by spending an extra 72 million pounds on improving primary care the health system would save 1.9 billion pounds by 2020.  By spending more on Medicare (now a specific health care program not a doctor’s bill payer) to implement these changes we could save many billions, as hospital care is so expensive. It is quite possible that the elimination of inefficient health spending as outlined in part one of this commentary could fund the changes.

    Lessons learnt from change management strategies in other health systems tell us that reform must be community supported and feature “bottom up” modelling. Clinicians would not be forced to adopt change with early implementation of the desired model involving a “coalition of the willing”. The latter should participate in establishing government funded “proof of concept” primary care services as described. How one laments that fact that the Super GP clinic money provided by the previous government could have readily funded a series of “medical homes”.

    For two decades John Menadue has championed the idea of a “proof of concept” demonstration of the value of whole of health care integration by creating a State/Commonwealth Health Commission in Tasmania to begin with,  wherein pooled funding would allow many of the above concepts to be trialled. Of course I would strongly support such an initiative for although, if successful, its importation to the mainland would leave us with many problems that could be solved by the re-alignment of health boundaries, patient focused integration and cost effectiveness would certainly be improved.

    I suspect that the Abbott government wants to reduce, as much as possible, its health footprint and would be happy to see health care handed over to the private sector. In every country where this has happened health expenditure has increased but not satisfactory health outcomes. The government’s initiation of a review of the benefits or otherwise of federalism may lead to a discussion of the possible assumption by States of all the public health care offered to their citizens. Any discussion that moves us away from the “status quo” is welcome. John Menadue’s three health policy reform blogs are informed and provocative and I hope will revitalise the reform debate.

    Medibank/Medicare was launched 40 years ago. It was designed to fund the health delivery system at that time.  We need now to address the basic issues concerning the way health services are delivered.

    I am grateful for the opportunity to add my comments.

    John Dwyer is Emeritus Professor of Medicine at UNSW.

     

     

     

     

     

     

     

  • John Dwyer. Commentary on John Menadue’s blogs on the barriers to health policy reform in Australia.  (Part 1)

    As I suspected  would be the case with many readers who enjoy “Pearls and Irritations”, I experienced in equal measure, satisfaction and frustration as I absorbed John  Menadue’s informed and insightful analysis of the problems that beset our health system and prevent urgently needed structural reforms. His three essays accurately explore the major issues. He has experienced political power and politician’s motivations from the inside. Fortunately, his passion for good government has, for two decades or more, been particularly interested in improving our health system. Here too, importantly, he has had first hand experience of how the system works (and doesn’t work). His recent survey provides us with a very valuable document, as it is, in fact, a template on which we must build a reform agenda.

    What about my feeling of frustration engendered by these essays?  While comprehensively exposed and explained, few of John Menadue’s conclusions are controversial among would be health system reformers who have first hand knowledge of the issues and who are studying the results of health system reforms in other countries. As he highlights, we have benefitted from political leadership willing to embrace major reforms to our financial systems but both sides of politics in Australia have failed us leaving health reform in the “too hard basket”. I remember a conversation with health minister Roxon on the need to introduce Integrated Primary Care into Australia.  She appreciated the benefits but as such a reform would increase Medicare expenditure she told me, “like many good ideas this will just have to lie on the table till the time is right”. The time was right 15 years ago.

    The comments that follow presume that readers will have read John Menadue’s important analysis. In this first part I will address some of the issues he presented and in a second part expand on the strategies need to progress reforms and what those reforms should embrace.

     

    As highlighted, the power of vested interests to urge lay politicians, who don’t understand our complex health system anyway, to hold to the “status quo” is frustrating. Recently “Australian Doctor” asked doctors (mainly GP readership) who was the least competent of the last ten health ministers. Peter Dutton won in a landslide but I feel this was a measure of current frustration rather than an historical analysis of the question.  I would have voted for Kay Patterson. As the new century started health reform advocates were active and the then minister for health in NSW, Craig Knowles, listened and accepted our argument that the next round of negotiations re commonwealth funding of state public hospitals should include a reform agenda not just a dollar agenda. The States and Commonwealth agreed and 13 sub committees were established to prepare structural reform agendas on everything from indigenous health to the funding of prevention strategies. After months of work and legitimate expectations that we were entering a new era for health reform, Minister Patterson pulled the plug on the reform agendas and reduced the COAG negotiations back to dollars. Had those reforms and the methodology for creating those reforms been accepted we would have a far better health system today. As John Menadue has highlighted here was another example of vested interests derailing a most important initiative.

    John Menadue emphasised the importance of every Australian having access to Medicare funded Primary Care with ability to pay being irrelevant to the quality of the service received.  Rightly, he warns us of the possibility of Primary Care becoming a two-tiered service with better access and facilities being available to those with private insurance. Such an arrangement has destroyed equity in the US system and dramatically pushed up costs. The Abbott government does not seem to understand that inequity is not only “unaustralian” it’s also very expensive. In 1900 the average Australian died aged 56. Many deaths were attributable to unavoidable and untreatable conditions particularly those caused by infectious organisms. The great flu pandemics did not discriminate between rich and poor. Today we can avoid most of those causes of early death and we live remarkably longer. Disease patterns today focus on dangerous life-style choices that lead to the development of Chronic and Complex problems which kill us slowly and for too many rob their extended years of life of quality. With the exception of poor health caused by excessive alcohol consumption all the risk factors for chronic disease are more prevalent among socio-economically disadvantaged Australians. We only spend 2% of our health budget on trying to help people avoid lifestyle induced illness and so we all end up paying much for the care of our fellow Australians with advanced disease.

    We need new money to fund important structural reforms so it’s appropriate that John Menadue looks at dollars we use poorly in our current system. He correctly targets the lack of leadership that has us paying far more for drugs than other similar countries. The duplication of health bureaucracies (nine departments of health for 23 million people) cost us 3-4 billion dollars annually, while the estimated 600,000 admissions to public hospitals that could have been avoided if the infrastructure for management in the community was available would save us at least 15 billion dollars. Over servicing by my profession when performing non-evidence based investigations and procedures of low value is estimated to cost 20 billion dollars a year. And then there is the Private Health Insurance Rebate that John Menadue discusses in detail.

    With some means testing now the rebate probably will cost taxpayers this year closer to 5 billion dollars rather than 7 billion but there is no doubt that the amount of health available from this initiative is not worth the price. While the Insurance industry and government disagree two facts are indisputable. The first is that the rebate has not been responsible for a significant number of Australians taking up private health insurance. After the introduction of the rebate, health insurance rose by no more than2%. The stick that did increase coverage was the whole of life rating system and tax accountants telling clients they would pay more tax if they did not sign up. The second fact is that the rebate and indeed the increased uptake of PHI did not reduce pressure on public hospitals. As John Menadue rightly points out increased activity in Private Hospitals where 75% of the patients have surgical problems, has seen a loss of surgical capacity in public hospitals greatly increasing the ability of surgeons to charge more while public hospitals are swamped with chronically ill medical patients and not able to offer as much timely surgery as they would wish.

    An obvious but important point emphasised by John Menadue reminded us that the PHI rebate and the pressure to hold PHI is vey unfair to many rural based Australians for there are no private hospitals available in the majority of rural communities. In truth many health inequities are entrenched in rural Australia. The 35% of Australians who live in the country and supply 66% of the nations wealth have far poorer health outcomes than their city cousins. White Australians living in rural communities are likely to live 4 years less than average city dwellers. From depression to heart disease to infant mortality to cancer, outcomes are inferior in rural Australia. This gross inequity is not being addressed despite numerous enquiries highlighting the changes needed to reverse the situation.  (e.g. reducing dependence on overseas trained doctors by training more rural based students in medical schools established in a rural setting and (as John Menadue emphasised) far better use of the existing non medical workforce, and numerous other evidence based strategies.) How frustrating for country citizens that the National party promised major rural reforms if the coalition won the last election when, in reality, they have had no power to influence rural health initiatives.

    Talking of the better use of the non-medical workforce brings me to one point where I would place a caveat beside one of John Menadue’s recommendations. Pharmacists are men and women trained at university to understand scientific methods and appreciate the importance of evidence based Medicine. Indeed their professional charter demands they only offer medicines know to be clinically effective to their clients. Certainly they should be integrated into our Primary Care system. However there is a professional (commercial) cancer eating away at their integrity as they offer so many products that have no real value to customers. Their prescription services are usually assigned to the back of a shop in which 80% of the space is provided to offering health products that are no doubt lucrative but of little value. Recently calls for Pharmacists to rid their shelves of Homeopathic products following the NH&MRC report emphasising they can have no more than a placebo effect, have been rejected. Pharmacists should be telling clients that the 2 billion dollars spent each year on supplements and vitamins is largely a waste of money and that you can’t neutralise an unhealthy lifestyle with something from a bottle.

    In many countries any clinical observations made and the drugs supplied to an individual are entered into the persons electronic health record in real time. John Menadue criticises the Department of Health for failing to roll out an electronic health record for Australians, an initiative he describes as a minor reform.  In fact an electronic health record is a much-desired major reform and can be the lynchpin for much needed integration of patient focused care. Many countries are now reporting on a decade of experience with an electronic health record and the improvement in care made possible by this initiative and clinician and patient satisfaction with the system are most impressive. Kaiser-Permanente in the US is reporting that in the last decade it has turned two million face to face consultations into email consults. The organisation’s initiatives, which include major prevention strategies delivered via an Integrated Primary Care system, have seen it have the best health outcome results nationally in 10 of the 12 major indicators used to measure success in treating chronic diseases.

    So summarising John Menadue’s concerns, we have a health system that by international standards is not meeting our contemporary needs, is provider, disease, and hospital centric, held hostage by vested interested that dissuade governments from embracing structural reform, is very cost ineffective, does not focus on efficiency and equity while Medicare, which though in need of reform remains invaluable to Australians, is at risk.  In the second section of this commentary I will comment and expand on John Menadue’s suggestions for breaking the impasse and providing a structure on which we might be able implement needed change.

     

    John Dwyer is Emeritus Professor of Medicine at UNSW.

     

  • John Menadue – 30th anniversary of Medicare

    John Menadue – 30th anniversary of Medicare

    This article was initially posted on 1st February last year, the 30th anniversary of Medicare. (more…)

  • John Menadue. Health Part 2 – what can we learn from overseas health services?

    Part 2 in this series was originally posted in August last year.

    In my blog of 6th October on what we can learn from overseas health systems, I drew attention and warned against government subsidised private health insurance. Any growth in this industry spells trouble for a good health service.

    Another thing that we could learn from overseas experience is that our fee for service (FFS) for GP consultation results in higher costs and inferior treatment. There are many disadvantages in FFS.

    • It drives up costs
    • It encourages ‘turnstile medicine’ whereby the GP earns more money the more patients he or she treats. It is sometimes called ‘ten minute medicine’. Follow up appointments are encouraged.
    • FFS leads to overprovision of care through over servicing. In Australia for example we see our doctor much more than patients in the UK or NZ where FFS is not practised at all or is being wound back.
    • For many patients with chronic or multiple health problems, FFS is inappropriate.
    • FFS is paid to the general practitioner in such a way that it discourages ‘team medicine’ and the use of other health professionals, particularly practice nurses, nurse practitioners and many other allied health persons, such as dieticians and physiotherapists.

    Many countries have moved away from FFS in favour of paying GPs, at least in part, on a capitation basis. Patients are enrolled in a practice and the GP is paid for ‘looking after them’. FFS may be appropriate for occasional care but it is not appropriate for long-term care of chronic patients.

    Capitation arrangements are widespread in NZ particularly for those with chronic healthcare problems. For 100 years capitation has been the principal means of paying GPs in the UK. In ‘managed care’ in the US capitation is widely used.

    A capitation scheme in Australia could not be introduced overnight but we need to scale back FFS to improve the quality of care and to discourage over-servicing and over prescribing. FFS is a perverse incentive. It rewards doctors when patients are sick. Doctors should be paid to keep people healthy.

    Another matter that we could learn from overseas is that we must find ways to overcome the split between commonwealth and state responsibilities in health. Broadly, the commonwealth funds general practice in the community and the states run public hospitals.

    This division of responsibility between hospital and non-hospital care is a major barrier to integrated and effective health care. Successful countries in health care, again like the Nordics and the UK, don’t have this split responsibility. They all have unitary systems with delegated health delivered  to local levels within a defined national policy.

    A major objective of any health service should be to keep people out of hospital. Hospital care is intrinsically more expensive and much more traumatic for patients. In his blog on August 20      Professor John Dwyer pointed out that if we had had a more effective integration of hospital and non-hospital care, we could have avoided 600,000 hospital admissions if there had been appropriate general practice care in the three weeks before hospital admission. That would be a very large saving.

    A good health service must have a strong grounding in primary care and general practice. This is one reason why the UK system is so good. In the UK they understand better than we do that hospitals should be the last and not the first resort.  Unfortunately government ministers put priority into iconic hospitals rather than primary care. We spent for too much in hospitals and not enough in primary care

    Primary and GP care provides the cheapest and best quality care and it can keep hundreds and thousands of people out of hospital. And when we have a good linkage between hospital and non hospital care, patients discharged from hospital can be effectively supported again by their local doctor.

    But because of our federal system the integration of hospital and non-hospital care is difficult. In my blog of June 3, 2014 I outlined a way to address this issue through a single funder in each state. This is fundamentally a political problem which causes difficulties in the health sector. Unfortunately commonwealth and state health ministers and their health bureaucracies seem more concerned about health territory rather than a health system that best serves our needs. The ‘blame game’  in health is unresolved.

     

  • John Menadue. Health Part 1 – what can we learn from overseas health systems?

    This article was initially posted in June last year.

    There has recently been quite a number of articles, including in The Conversation, about what we can learn from overseas health systems.

    Before looking at these international comparisons, it is worth reminding ourselves that we do have a pretty good health service in Australia. It is not as good as it should be, but Medicare has stood the test of time since 1974. It costs less than the average of all OECD countries, as a percentage of GDP. Nevertheless there are some things that we can learn from overseas experience that should guide us.

    In my view the most important thing we can learn from overseas experience is to be extremely wary of corporate welfare to the private health insurance industry. If it is allowed to grow in Australia through government subsidies it will represent a major challenge to an efficient and universal system of health care. The taxpayer subsidy to the private health insurance industry in Australia is about $5b billion per annum. That subsidy is about three times the annual subsidy which we used to pay to our automobile industry. Private health insurance is an expensive financial intermediary that does not deliver any health services.

    The evidence around the world is clear that private health insurance is both extremely costly and very unfair. At one end of the spectrum is the US which has one of the worst health systems in the world in terms of equity and value for money. It is horrendously expensive. That is due largely to the fact that the funding of so much of health care in the US depends on private health insurance.

    Americans pay about 8% of their GDP in private health insurance premiums. These premiums are really private taxes. If these premiums could be transferred to the federal government, the US would have a better health service through a single funder and it would also eliminate in one swoop the US federal deficit. See my joint blog with Ian McAuley of December 26, 2013.  The scale of these private health premiums in the US gives some idea of the cost and the political power that private health insurance brings to bear. Experience in the US shows that a multitude of private health insurers cannot control costs and they weaken the power of the public funder to do so as well.  President Obama may have expanded coverage of health care but reliance on private health insurance instead of a strong public payer, or price control, means that he will not be able to control costs.

    At the other extreme in private health insurance is the UK and the Nordics who all have strong public funders and health service and with little or no reliance on private health insurance. The result is that these countries have amongst the best health services in the world.

    The growth of private health insurance in Australia is the greatest risk we face in health… This threat should not be underestimated. The $5 billion p.a. subsidy should be abolished and transferred to a Medicare Dental scheme. This would shore up Medicare as a strong public funder for the future and expand the coverage of Medicare.

    But the signs are that the Coalition Government wants to go in the opposite direction and extend private health insurance. We know from experience in this country that the administrative cost of private health insurance are three times higher than Medicare, that private health insurance favours the wealth and , that private health insurance particularly through gap insurance  makes it more difficult for Medicare to control costs because of such policies as gap insurance. Furthermore private health insurance has not taken pressure off private hospitals.

    Private health insurance enables the wealthy to jump the hospital queue ahead of other people. The private health insurance industry is now trialling in Queensland, and is lobbying to extend its role into general practice. An inevitable outcome of that would be that privately insured patients would be able to jump the queue in seeing their general practitioner.  But there is more from these destructive private health insurers. Despite the denial by the CEO of Medibank Pte, George Savvides, the AMA insists that Savvides told an AMA dinner in March this year that he would like to see private health insurance policy holders receiving priority in admission and treatment in emergency departments of public hospitals.

    International warnings are clear. Private health insurance is a real threat to an efficient and equitable health service. Maintaining Medicare as a single funder of health services in a critical issue.

    Whether health services are delivered by the private sector or the public sector is a secondary issue. For example in Australia at the moment private medical services are overwhelmingly delivered by private doctors even though Medicare is a public funder. Health services should be delivered by people and organisations that can ensure quality and best value for money. But a single public funder is essential in my view.

    The private health insurance lobby in Australia is unremitting. It never convincingly argues its case. It relies heavily on secret lobbying. Before the 2007 election the industry made a secret deal with Kevin Rudd that a Labor Government would maintain the government subsidy for private health insurance.

    If people want to waste their money on private health insurance that is their choice. But it is extremely bad public policy for taxpayers to subsidise this pernicious industry. Warren Buffet described private health insurance as the tapeworm in the American health service.

    It is the same problem in Australia and we must resist any growth in taxpayer subsidised private health insurance that would take us closer to an American style disaster.  The corporate privileges for the inefficient and dangerous private health insurance sector must be rolled back.

    That is the most important lesson to learn from looking at overseas health services.

  • US Government unveils goal to move Medicare away from fee-for-service.

    On 27/28 and 29 January 2015 I posted three articles on Health Policy Reform. One issue I discussed was the major problem of fee-for-service (FFS) as a means of remunerating doctors. Such a scheme remunerates quantity rather than quality of service.

    On 26 January, the US Health and Human Services (HHS) Secretary, Sylvia M. Burwell, outlined a major change in the way that doctors and hospitals will be remunerated in future. She said ‘HHS has set a goal of tying 30% of traditional, or fee-for-service, Medicare payments to quality or value through alternate payment models.  … Today’s announcement would continue the shift towards paying providers for what works, whether it is something as complex as preventing or treating disease, or something as straight-forward as making sure a patient has time to ask questions’.

    See statement by Sylvia M. Burwell below. Australia is increasingly out of touch as we cling to fee-for-service style payments. We are lagging behind most developed countries with FFS and even the US which has the most expensive and inefficient health services in the world.

    Better, Smarter, Healthier: In historic announcement, HHS sets clear goals and timeline for shifting Medicare reimbursements from volume to value

    In a meeting with nearly two dozen leaders representing consumers, insurers, providers, and business leaders, Health and Human Services Secretary Sylvia M. Burwell today announced measurable goals and a timeline to move the Medicare program, and the health care system at large, toward paying providers based on the quality, rather than the quantity of care they give patients.

    HHS has set a goal of tying 30 percent of traditional, or fee-for-service, Medicare payments to quality or value through alternative payment models, such as Accountable Care Organizations (ACOs) or bundled payment arrangements by the end of 2016, and tying 50 percent of payments to these models by the end of 2018.  HHS also set a goal of tying 85 percent of all traditional Medicare payments to quality or value by 2016 and 90 percent by 2018 through programs such as the Hospital Value Based Purchasing and the Hospital Readmissions Reduction Programs.  This is the first time in the history of the Medicare program that HHS has set explicit goals for alternative payment models and value-based payments.

    To make these goals scalable beyond Medicare, Secretary Burwell also announced the creation of a Health Care Payment Learning and Action Network.  Through the Learning and Action Network, HHS will work with private payers, employers, consumers, providers, states and state Medicaid programs, and other partners to expand alternative payment models into their programs.  HHS will intensify its work with states and private payers to support adoption of alternative payments models through their own aligned work, sometimes even exceeding the goals set for Medicare.  The Network will hold its first meeting in March 2015, and more details will be announced in the near future.

    “Whether you are a patient, a provider, a business, a health plan, or a taxpayer, it is in our common interest to build a health care system that delivers better care, spends health care dollars more wisely and results in healthier people.  Today’s announcement is about improving the quality of care we receive when we are sick, while at the same time spending our health care dollars more wisely,” Secretary Burwell said. “We believe these goals can drive transformative change, help us manage and track progress, and create accountability for measurable improvement.”

    “We’re all partners in this effort focused on a shared goal. Ultimately, this is about improving the health of each person by making the best use of our resources for patient good. We’re on board, and we’re committed to changing how we pay for and deliver care to achieve better health,” Douglas E. Henley, M.D., executive vice president and chief executive officer of the American Academy of Family Physicians said.

    “Advancing a patient-centered health system requires a fundamental transformation in how we pay for and deliver care. Today’s announcement by Secretary Burwell is a major step forward in achieving that goal,” AHIP President and CEO Karen Ignagni said. “Health plans have been on the forefront of implementing payment reforms in Medicare Advantage, Medicaid Managed Care, and in the commercial marketplace. We are excited to bring these experiences and innovations to this new collaboration.”

    “Employers are increasingly taking steps to support the transition from payment based on volume to models of delivery and payment that promote value,” said Janet Marchibroda, Health Innovation Director and Executive Director of the CEO Council on Health and Innovation at the Bipartisan Policy Center. “There is considerable bipartisan support for moving away from fee for service toward alternative payment models that reward value, improve outcomes, and reduce costs. This transition requires action not only by the private sector, but also the public sector, which is why today’s announcement is significant.”

    “Today’s announcement will be remembered as a pivotal and transformative moment in making our health care system more patient- and family-centered,” said Debra L. Ness, president of the National Partnership for Women & Families. “This kind of payment reform will drive fundamental changes in how care is delivered, making the health care system more responsive to those it serves and improving care coordination and communication among patients, families and providers. It will give patients and families the information, tools and supports they need to make better decisions, use their health care dollars wisely, and improve health outcomes.”

    The Affordable Care Act created a number of new payment models that move the needle even further toward rewarding quality.  These models include ACOs, primary care medical homes, and new models of bundling payments for episodes of care.  In these alternative payment models, health care providers are accountable for the quality and cost of the care they deliver to patients. Providers have a financial incentive to coordinate care for their patients – who are therefore less likely to have duplicative or unnecessary x-rays, screenings and tests.  An ACO, for example, is a group of doctors, hospitals and health care providers that work together to provide higher-quality coordinated care to their patients, while helping to slow health care cost growth. In addition, through the widespread use of health information technology, the health care data needed to track these efforts is now available.

    Many health care providers today receive a payment for each individual service, such as a physician visit, surgery, or blood test, and it does not matter whether these services help – or harm – the patient. In other words, providers are paid based on the volume of care, rather than the value of care provided to patients. Today’s announcement would continue the shift toward paying providers for what works – whether it is something as complex as preventing or treating disease, or something as straightforward as making sure a patient has time to ask questions.

    In 2011, Medicare made almost no payments to providers through alternative payment models, but today such payments represent approximately 20 percent of Medicare payments. The goals announced today represent a 50 percent increase by 2016. To put this in perspective, in 2014, Medicare fee-for-service payments were $362 billion.

    HHS has already seen promising results on cost savings with alternative payment models, with combined total program savings of $417 million to Medicare due to existing ACO programs – HHS expects these models to continue the unprecedented slowdown in health care spending.  Moreover, initiatives like the Partnership for Patients, ACOs, Quality Improvement Organizations, and others have helped reduce hospital readmissions in Medicare by nearly eight percent– translating into 150,000 fewer readmissions between January 2012 and December 2013 – and quality improvements have resulted in saving 50,000 lives and $12 billion in health spending from 2010 to 2013, according to preliminary estimates.

    To read a new Perspectives piece in the New England Journal of Medicine from Secretary Burwell:http://www.nejm.org/doi/full/10.1056/NEJMp1500445

    To read more about why this matters: http://www.cms.gov/Newsroom/MediaReleaseDatabase/Fact-sheets/2015-Fact-sheets-items/2015-01-26-2.html

    To read a fact sheet about the goals and Learning and Action Network:http://www.cms.gov/Newsroom/MediaReleaseDatabase/Fact-sheets/2015-Fact-sheets-items/2015-01-26-3.html

    To learn more about Better Care, Smarter Spending, and Healthier People:http://www.cms.gov/Newsroom/MediaReleaseDatabase/Fact-sheets/2015-Fact-sheets-items/2015-01-26.html

    Participants in today’s meeting include:

    • Kevin Cammarata, Executive Director, Benefits, Verizon
    • Christine Cassel, President and Chief Executive Officer, National Quality Forum
    • Tony Clapsis, Vice President, Caesars Entertainment Corporation
    • Jack Cochran, Executive Director, The Permanente Federation
    • Justine Handelman, Vice President Legislative and Regulatory Policy, Blue Cross Blue Shield Association
    • Pamela French, Vice President, Compensation and Benefits, The Boeing Company
    • Richard J. Gilfillan, President and CEO, Trinity Health
    • Douglas E. Henley, Executive Vice President and Chief Executive Officer, American Academy of Family Physicians
    • Karen Ignagni, President and Chief Executive Officer, America’s Health Insurance Plans
    • Jo Ann Jenkins, Chief Executive Officer, AARP
    • Mary  Langowski, Executive Vice President for Strategy, Policy, & Market Development, CVS Health
    • Stephen J. LeBlanc, Executive Vice President, Strategy and Network Relations, Dartmouth-Hitchcock
    • Janet M. Marchibroda, Executive Director, CEO Council on Health and Innovation, Bipartisan Policy Center
    • Patricia A. Maryland, President, Healthcare Operations and Chief Operating Officer, Ascension Health
    • Richard Migliori, Executive Vice President, Medical Affairs and Chief Medical Officer, UnitedHealth Group
    • Elizabeth Mitchell, President and Chief Executive Officer, Network for Regional Healthcare Improvement
    • Debra L. Ness, President, National Partnership for Women & Families
    • Samuel R. Nussbaum, Executive Vice President, Clinical Health Policy and Chief Medical Officer, Anthem, Inc.
    • Stephen Ondra, Senior Vice President and Chief Medical Officer, Health Care Service Corporation
    • Andrew D. Racine, Senior Vice President and Chief Medical Officer, Montefiore Medical Center
    • Jaewon Ryu, Segment Vice President and President of Integrated Care Delivery, Humana Inc.
    • Fran S. Soistman, Executive Vice President, Government Services, Aetna Inc.
    • Maureen Swick, Representative, American Hospital Association
    • Robert M. Wah, President, American Medical Association
  • John Menadue. Health Policy Reform: Part 3 – Principles for reform

    In Part 1 of this series I described the areas in our health sector that need reform. In Part 2 I spoke of the obstacles, particularly those imposed by vested interests in the health sector to protect their own interests by delaying or stopping reform. In this article, I will be suggesting ways in which we can overcome these obstacles to health reform. But make no mistake: it will be hard without political leadership and political will.

     

    Don’t rush the process

    The political process encourages parties seeking election or re-election to address problems with high political salience – waiting lists in public hospitals, needs among certain groups with chronic illness, and identified funding gaps. The political response is to develop specific proposals, usually involving carefully-calculated calculations of budgetary costs.

    Such a process, while providing short-term solutions to proximate problems, fails to address the structural problems identified in Part 1 – the fragmented nature of our health care arrangements, inequities, gaps in services, such as dental care, the allocation of resources towards high-cost hospital interventions at the expense of promotion, prevention and primary care, and the distortions associated with private health insurance.

    It also privileges those vested interests outlined in Part 2, who can mobilize resources to block all but the most minor reforms.

    Those pursuing reform need to go over the heads of the vested interests and find out what the community really wants, rather than paternalistically assuming that they know what’s best. In recent years the paternalistic assumption has been that the community prefers tax cuts to improved health services, even though evidence tends to point in the opposite direction.

    System-wide reform takes time. And it takes open minds. Governments need to realize that even when they can set aside their own financial or professional interests, “insiders” find it hard to imagine any significant departures from existing arrangements. That was a major shortcoming of the Rudd Government’s Health and Hospital Reform Commission. Outside perspectives are important.

    In order to lift the process beyond immediate concerns, those pursuing reforms can set out a basic set of principles, and, in a well-managed consultation process, can inform the community of options, and invite the community to discuss and agree or amend these principles. Such a path to reform contrasts with the quick-and-dirty proposals which emerge from processes such as the Abbott Government’s Commission of Audit. Rather, reform can draw on the tradition of white paper – green paper policy development and the reform process pursued by the Hawke-Keating Government. The Senate Committee system should also be utilised.

    Guiding principles

    As in any public policy the basic principle should be pursuit of efficiency and equity. Contrary to some simplistic notions, there is not necessarily a trade-off between these principles. An inefficient system is a high-cost system, and a high-cost system generally tilts the balance towards those who have most ability to pay. That is the basic failure of the United States system.

    Economic considerations should extend beyond governments’ own fiscal costs. Rather they should take into account costs and benefits throughout the community. There is no benefit in saving people $1.00 in taxes through Medicare if the result is that they have to pay $1.10 of $1.50 for the same or inferior services in private markets through PHI.

    Equity should be concerned with ensuring that income, wealth or personal influence does not give individuals preference in treatment, displacing those with greater needs but lesser means.  A related principle should be one of solidarity or social inclusion. This means that all should have access to the same high-quality services, rather than a segregated system with special services for the poor or “indigent”, to use the derogatory American term. In Australia we should resist most strongly the conservative notion that Medicare should be reduced to a safety net for the poor. The same high quality service should be available for all .While people with different means may make different payments, they should all be using the same services. The present “two tier” arrangements, where those with means are more likely to use private hospitals, violate this principle.

    Within such a shared system, there should be scope for users to exercise autonomy and choice, so long as these do not impose costs on other users. Financial incentives on providers and users should not detract from the principles of personal responsibility. Health care services need to be perceived as components of a set of policies promoting good health. In this regard, the community’s health should be seen as an asset worthy of attention in all government policies – taxation, urban design, trade agreements (patents), labour relations and wages policy, social security, environmental protection, sport etc. Public health should be of concern across all portfolios, and health ministers, state and federal, should have the same standing as treasurers.

    The government should consider alternatives to fee-for-service remuneration for primary care and other services. The New Zealand Government, for example, pays episodic care by doctors on a fee-for service basis but chronic care is paid on an annualized basis.

    Health programs should have a user focus, rather than a provider focus. The user drawing on different services should not have to confront multiple institutions with their own funding arrangements, records and protocols of care. Policies should aim to integrate and not merely coordinate medical services, pharmaceutical care, hospital care and rehabilitation. Such flexibility should be guided by the principle of subsidiarity. That is, services should be managed at the most feasible local level, provided such autonomy does not conflict with needs for central standards in important areas.

    Funding needs to be based on a judicious balance between individual (“out-of-pocket”) payments and pooled payments. While a lack of means should never present a barrier to those who need care, there is no reason why those with means should not make personal contributions.

    The balance between individual and collective funding is one which needs community consultation. There are arguments for a completely free, tax-funded system, and there are arguments for more individual payments where price signals play a role, but the choice needs to be put to the community in a way that explains the costs and the benefits of each method of payment. Most probably the community, presented with an informed choice, will opt for some balance.

    For that proportion of costs the community chooses to share, this sharing should be through a single national insurer, with the capacity to use its purchasing power to keep costs under control, and guided by principles of ensuring access for those with limited means and covering all against high expenses. As with other high-cost and heavily-subsidised industries, such as clothing and footwear, the $7b plus per annum subsidy to PHI should be steadily phased out. If people wand private health insurance that is their right but there is no reason for the taxpayer to provide a subsidy.

    While the government should take responsibility for pooled funding, provision of health services should allow for both government and private involvement. In regulated markets private providers should be assured of reasonable returns on their investments (including their investment in human capital), but they should not be permitted to take advantage of any privileged position in the market. Public policies should recognize that commercial incentives which are about expanding markets and good public policy which is often about encouraging personal responsibility and reducing dependence on health services do not always align.

    All systems of remuneration, to private or public providers, should be subject to full accountability, and all services should be subject to the general principles of competition policy but without promoting competition where it serves no public purpose, such as a proliferation of look-alike high-cost private insurers. Accounting systems should expose all instances of cost-shifting – from Commonwealth to state governments, from governments to individuals, and from present outlays to future outlays. While there may be reasons for costs to be reallocated between different parties, such reallocations should be for reasons of equity or efficiency, and not for budgetary impression management.

    All health care services should be subject to professional governance and accountability, with clear charters of responsibility but at arm’s length from executive government. We really don’t know much about how doctors perform in private practise. We hear about occasional mal practise but very little about general performance and competence.

    The related issue of Commonwealth-state relations needs resolution. There are many possible paths to reform. One possibility for consideration is for health services to be administered by joint Commonwealth-state commissions in each state, with pooled Commonwealth and state funding. Tasmania with its small and comparatively aged population could provide the basis for a trial.  See link to ‘The Blame Game in Health’ that I posted on 3 June last year  https://publish.pearlsandirritations.com/blog/?p=1756/.

    The role of institutions

    Health reform is too important to be left to health departments particularly the Commonwealth Department of Health and Ageing and bodies with superficial mandates such as the recent Commission of Audit.

    Fortunately the Commonwealth has bodies such as the Productivity Commission, an organisation with not only technical expertise to analyse policy proposals, but also with the capacity to sound out those with policy interests. It gives all a forum to voice their concerns, to tease out likely unintended consequences of policy proposals, and to direct corporate interests to contribute to problem-solving and policy design rather than to defending their vested interests. Most important, it can bring an “outside” view to public policy, addressing questions and options that may be beyond the imagination of “insiders”.

    While the Productivity Commission can bring forth practical recommendations, the questions in health reform are so basic, however, that they require a wider and more inclusive process before specific issues can be addressed. Questions such as how costs are shared, and how scarce resources should be allocated, particularly for high-cost interventions with minor benefits, involve basic moral considerations.

    One possibility is to establish a Health Reform Commission composed of independent and professional people to inform and lead public discussion and advise on important health reform issues. Clinicians should be included, but not the AMA or any of the vested interests. The Law Reform Commission established by the Whitlam Government in 1975 is an example of how enquiries and consultations can be conducted with the community in order to make recommendations to government that are well-informed. The Law Reform Commission estimates that over 85% of its reports have been either substantially or partially implemented making it an effective and influential agent for reform. The Reserve Bank is another example of how a respected, professional and independent body can be a leader in public discussion of important issues. A major objective of a Health Reform Commission would be to outflank the vested interests and carry an informed discussion with the community, particularly of the key principles that should drive health care. Ahead of establishing such a commission in government it would be useful to establish an interim group of professional and independent people who can facilitate informed public discussion and provide advice.

    There are various ways to deal with public participation but the basic approach and method is that communities should be consulted to find what they want, and in successive rounds experts should analyse and report back on the costs and consequences of their proposals. For example, explaining that a completely free system would involve higher taxes and may involve greater waiting times.

    One other model is the “citizen jury” – so named because the citizens to be consulted are selected on a random basis, and are informed by professional and independent experts. They could be asked to provide their advice back to government on such key issues as: to what extent do we want to share the costs of healthcare; how co-payments should be reformed; how to overcome the commonwealth state blame game; how the workforce should be reformed.  End of life issues could also be canvassed as well as many expensive interventions that have limited effectiveness. These citizens’ juries in health could be important vehicles for a national conversation on health, a conversation that we do not have at present.

    I see parts 1,2and 3 on Health Policy Reform as outlined as, hopefully, a means to put the debate on health reform onto a more constructive and pragmatic path. Unless we get our processes working more effectively and particularly how to bypass vested interests, reform will continue to be very difficult. When we improve our processes we can be more confident of addressing the particular policy issues outlined in these three papers.

    Unless we address the issue of power and how and who exercises that power in the health sector we will not achieve worthwhile reform. Power is in the hands of providers. It is not in the hands of the public or governments. That is the key issue. We need leadership, institutions and processes to focus on how we overcome this central issue.

  • John Menadue. Health Policy Reform: Part 2 – Why reform is difficult. Health ministers are in office but not in power.

    In Part 1 on health policy reform I outlined the main areas where health reform is necessary. In Part 2 I examine the reasons why I think health reform is so hard. In part 3 I will consider ways in which the necessary path of health reform can be quickened.

    There is a major barrier to health reform. It is the power of providers or at least their assumed power. When I was asked by the National Hospital and Health Reform Commission to describe in a sentence or even one word the obstacles to health reform I said ‘power’, the power of providers. I don’t the Commission got what I was driving at!

    A succession of Australian health ministers may have been in office but they have not been in power. Aneurin Bevan who launched in the 1940’s in my view the best health service in the world knew a few things about health but more importantly he knew much more about political power and how to exercise it in the public interest. He drew on the strong support of the community, a minority of doctors and the majority of nurses. He won the day and not surprisingly the UK National Health Service was the centre piece at the London Olympic opening ceremony in 2012.

    The previous Australian health minister said we needed a conversation on health. The new minister says she will consult widely after the fiasco on co-payments. But if past practise repeats itself the conversation and consultation will be limited to the AMA and the Pharmacy Guild.

    The difficulties of sensible reform are obvious in the health field but they are a generic problem in public policy today. It has been most obvious in climate change policy where Ross Gaunaut has described the power of vested interests as a ‘diabolical problem’.

    The power of insiders – or the faintheartedness of politicians

    Reform disrupts established arrangements. In general, the longer those arrangements have persisted, the greater becomes the pent-up need for reform, meaning that reform is going to be disruptive to existing interests. By the same token, as arrangements become more entrenched, the more do those who benefit from them feel threatened, and the more political clout they develop to resist reform.

    That resistance is often based on financial self-interest, but it also aligns with a general fear of change and professional conservatism. It is difficult for those who are “inside” a system – be they administrators, professionals or policymakers – to conceive of other ways of delivering services.  Institutional inertia is a strong force. And in health care it is easy to lose sight of the fact that delivering services is not, in itself, the objective. That objective surely is serving the community by helping to keep the population healthy.

    One group with a stake in current arrangements are those who administer health services. Health is a highly technical, large and complex field that is difficult for outsiders to come to grips with. This gives disproportionate power to health administrators on the inside.

    “Joined at the hip” with these administrators are much the same vested interests (rent seekers) that batten on the health service and dominate the public debate. These are much the same vested interests who so selfishly and ferociously led the opposition to Medibank in 1975. They are still with us today but in a different guise. The AMA has a long and dubious history in opposing key health reforms going back to its opposition to the Pharmaceutical Benefits Scheme In 1942.

    These vested interests include the Australian Medical Association (AMA), the Australian Pharmacy Guild, the private health insurance funds, Medicines Australia and the state and territory health department bureaucracies. In addition, there is a general “pro-business” push to open up all aspects of health care more to the private sector, particularly pathology and radiology.

    The AMA in its role as a medico- political organisation opposes reform of the fee for service (FFS) system of remuneration. FFS is an administratively convenient means of remuneration, but it carries perverse incentives because it rewards over-servicing, over-referring and over-prescribing. It is particularly inappropriate for care of the chronically ill.

    Even among the most dedicated professionals, financial incentives influence behaviour, and tend to reinforce professionals’ desire to apply their skills to problems – rather than encouraging people to become less dependent on health services.

    Where possible, financial incentives should encourage practitioners to keep people healthy, rather than to deliver services to the sick. There is no “one-size-fits-all” method of remuneration – FFS has its place, but it should stand alongside other systems, such as capitation and salaried payments.

    The perverse incentives in FFS come to play particularly strongly when health care takes on a corporate structure, where business objectives such as return on shareholders’ funds displace professional service objectives traditionally associated with medical practices. Businesses operate on the basis of expanding their markets, not on the basis of telling customers they may be over-using their services. The AMA, however, is turning a blind eye to the growing corporate takeover of general practise and the associated vertical integration into radiology and pathology.

    Excuse me for dropping names but in a round table I attended with Margaret Thatcher in the late 1980s she was asked, “Now that you have fixed the restrictive work practices of the miners and the printers, what are you going to do about the restrictive work practices of the doctors? She replied that she would leave it to her last term. She never got around to it.” And so far neither have we.

    The Pharmacy Guild strongly defends the privileged position pharmacists have gained through political influence. On the one hand the Guild strongly defends the many restrictions on competition enjoyed by pharmacists – prohibition on pharmacies in supermarkets, prohibition on price advertising, restrictions on location of pharmacies and exclusive rights to sell many non-prescription medications. On the other hand it does nothing to encourage integration of pharmacy with general practice. Thus there persists the anachronistic practice of a separation of pharmaceutical from medical services.

    It is not only in retail pharmacy that Australians are overpaying. Governments are also generous with taxpayers’ money for the mainly foreign pharmaceutical firms who are able to exploit their power in patents. Medicines Australia, the body representing manufacturers and distributors of drugs, has successfully lobbied the Commonwealth to pay high prices for prescription pharmaceuticals. Twenty years ago Australia stood out as a world leader in using government purchasing power to keep pharmaceutical prices under control. Now Australia pays top prices: for example, Australians pay $2 billion per annum more than New Zealanders pay for equivalent drugs.

    The private health insurance companies are expensive financial intermediaries, receiving a $7b annual taxpayer subsidy through the rebate, and additional support in the form of the Medicare Levy Surcharge, which subsidises those with high incomes to hold PHI. Not even at the height of manufacturing industry protection were people actually given cash subsidies to buy Holdens and Falcons.

    Private insurers don’t deliver any health services; they are simply high-cost financial intermediaries taking commissions. As I outlined in Part 1, PHI benefits the wealthy and most importantly weakens the power of Medicare to control prices. Gap insurance through PHI has underwritten an enormous increase in specialist fees. Now the private insurers are edging their way into general practice. The Managing Director of Medibank Private also reportedly told doctors that private health insurance policy holders should have priority in public emergency departments. What an outrageous proposal.

    Government subsidized private insurance is a major threat to health care in Australia. At first sight it may appear to relieve public budgets and to take pressure off public hospitals, but that’s not the way it plays out. It actually sucks resources out of the public hospitals. The remeration of most specialists in private hospitals are multiples of the remuneration of specialists in public hospitals. And as PHI pushes up costs, governments, still left with funding a large part of health services, find that they become passive players, accepting prices set by private service providers and insurers. As a result, In the United States the government’s partial programs – Medicare and Medicaid – now cost more as a proportion of GDP than do completely publicly-funded insurance systems in the United Kingdom and many other European countries. The cause of this problem in the US is PHI.

    Yet, in spite of this economic danger, and the example of the clearly dysfunctional American system, governments in this country – Coalition and Labor – have been reluctant to take on the PHI industry. Before the 2007 election Kevin Rudd wrote to the industry assuring it that their taxpayer subsidies would continue.

    In an economy where many traditional industries, from manufacturing through to print media, are facing huge competitive pressure and disruption, health care is seen as one last remaining growth sector, offering easy picking for business – if only the government would get out of the way.

    Those are the private interests. We also have eight state and territory health department bureaucracies supported by their ministers. In a nation where state governments feel that more and more financial and political power is accruing to the Commonwealth, it is natural that they defend their shrinking turf. Such considerations override any concern to see an integrated national system. In response, the Commonwealth is reluctant to stare down the parochialism of the states.

    Reform is possible

    Australian governments have a strong record on economic reform. In the 1980s the Hawke-Keating Government took on vested interests, and negotiated a wide-ranging set of reforms in the manufacturing, transport and financial services industries. Earlier, in the mid-1970s, the Whitlam Government, when it introduced Medibank, successfully stared down the AMA and the health insurers. Although the Fraser Government unwound many of these reforms, the Hawke Government successfully resurrected universal public insurance in the form of Medicare.

    But there has been no significant reform of the health sector since then. In 1977 the Productivity Commission recommended a comprehensive inquiry into health financing, but no government has initiated such an inquiry. Corporate interests have become more involved in health care, and PHI has become established once again.

    Governments generally over-estimate the power of lobby groups. They can make a lot of noise – particularly when, as a result of successful rent-seeking in the past, they have accumulated large funds to spend on scare campaigns at the public’s expense, but the capacity to make noise does not equate to a capacity to influence voters. Opinion polls consistently show that the public believe Coalition governments are too much influenced by big business, which means reforming governments should be able to gain electoral advantage from standing up to rent-seekers.

    The problem is not just about financial self-interest, however. It is also about the inertia of established practices, and an incapacity of those on the “inside” to imagine any significant variation on current arrangements. Practices such as the separation of pharmacies from medical services, fee-for-service funding, the dependence of private hospitals on private insurance, the separation of medical from hospital services in private hospitals, and so on, have become entrenched in the thinking of policymakers, politicians and many journalists. There is a deficit of imagination, an incapacity to think beyond the present.

    A large part of the problem lies in the Commonwealth bureaucracy. Commonwealth Ministers for Health are very dependent on the Department of Health and Ageing, particularly, as is often the case, when ministers are not across the issues and don’t have a clear policy program themselves. Aneurin Bevan showed how important political leadership is.

    The Department is ill-equipped to cope with policy reform. Rather, its objective seems to be to keep the peace with provider lobbies, and to keep the minister out of any public brawl or argument.

    The Department is structured in ways that reflects the interests of providers such as doctors and pharmacists, rather than on the basis of community interests, such as acute care, chronic care or demography. It has expertise in administering existing programs but it has little economic expertise. Fiscal concerns tend to crowd out any consideration of economics.  One very senior Commonwealth official said to me that the Department does not have any strategic sense in health policy.

    In fact the Department doesn’t even effectively integrate the Commonwealth’s own major programs, let alone make any real progress in bridging the Commonwealth and state divide. During the difficult negotiations with the states on health reform during the Rudd Government period, the Department of Prime Minister and Cabinet effectively had to step in because DHA was not up to the job. Even the task or rolling out e-health, a minor but important reform, proved to be a difficult one for the Department. DHA sees Medicare as a funding vehicle and not a policy instrument. Medicare is, in fact, is not even within DHA. Health policy is an after-thought and health reform is right off the agenda.

    The Ministerial/Departmental model in health has failed. It is incapable of contesting the power of the rent seekers. The community is effectively excluded.

    Unless the health debate is taken to “outsiders”, away from the insiders – the rent seekers and vested interests– we are unlikely to see significant progress in health reform. The vested interests invariably win out over the public interest, time and time again.

    Political struggles between the public and rent-seekers are not uncommon, but there are reasons why in health care the public interest has a hard time securing a voice. Most of the public most of the time have little contact with health services. The intense users tend to be the chronically ill (who are reasonably active but do not constitute a majority) and those who are nearing the end of their lives and are not in a position to exert political influence. It is unlike services we all experience such as education or transport, where strong public lobby groups naturally arise. Also, health lobby groups are able to exploit the public’s trust in health care provider’s services – a trust which is well-justified on the grounds of professional competence, but which should not logically extend to trust on financial or political matters.

    The media stories tend to be about failures – often in public hospitals because they handle the most difficult cases – and about corporate activities. Press releases from pharmaceutical firms, health insurers and other rent-seekers provide easy material for under-resourced journalists. It is easy for governments and so-called “business interests” to raise scare campaigns about the affordability of government health services. They don’t mention that when those services are privatized they are generally more expensive), but it is very hard to engender a debate about health policy. The superficial slanging match about the Commonwealth’s GP co-payments is illustrative of the paucity of the public “debate”.

     

    In Part 3 I will address governance and issues of process which are necessary to break through the inertia and counter the power of the vested interests that batten on the health system.

     

  • John Menadue. Health Policy Reform: Part 1 – Why reform is needed.

    I will be posting three articles on health policy.

    This article outlines the priority areas where reform is necessary.

    Part 2 will explain why reform is so difficult but not impossible. The key issue is power and how it is exercised

    Part 3 will be about processes and governance issues that are necessary to move us beyond the present inertia, incrementalism and tinkering, with suggestions for policy directions. I will not be proposing specific policies. 

    The Rudd-Gillard Government – lost opportunities

    Traditionally, in Australia and elsewhere, Labor and similar governments have been the initiators of health reform. Conservative governments, in general, have opposed or wound back health reform.

    In Australia the Labor Party, guided by principles of universalism, equity and economic efficiency, gave us publicly-funded health insurance – initially through Medibank and then through Medicare.

    In spite of high expectations in health reform, however, in its 2007-2013 period in government Labor really did little more than muddle through. Kevin Rudd promised to take over state hospitals if the states continued to stonewall, and polling suggested that the public agreed with his approach. But in the end he gave way: fragmentation of services between the Commonwealth and the states continued, as did the practices of cost and responsibility shifting between those two tiers of government. He focussed on hospitals and not on primary care.

    The Rudd Government established a National Hospital and Health Reform Commission (NHHRC), but it was composed largely of health insiders who seemed to be incapable of seeing health policy from a broad perspective, and who failed to grasp the basic economics of health care. The process achieved very little and chewed up a great deal of time and money. It was a wasted opportunity.

    To its credit the Rudd and Gillard Governments had one major policy achievement – plain-packaging of cigarettes, and before it lost office was making progress on other aspects of public health. The success of these public health reforms, in contrast with the minor achievements of health care programs, is consistent with the possibility that reform of these programs is impeded by institutional inertia and the power of rent-seekers, a point taken up in Part 2. The tobacco industry is well-heeled, but it does not have friends in health departments.

    Case mix funding to improve hospital efficiency was also a useful reform

    Indigenous, mental and rural health all remain in a parlous state. Health programs operate in isolation from one another. The funding of health care through multiple public, corporate and private channels results in serious inequities. And, in general, there are administrative inefficiencies and a poor allocation of scarce resources.

    Since 2013 the situation has worsened. The Abbott Government has abolished the Australian National Preventive Health Agency and Medicare Locals, has foreshadowed deep cuts in funding for state hospitals, and has put up ill-considered proposals for GP co-payments.

    Getting the most from what we have

    In considering health reform, we need to start with an appreciation that we have one of the best health services in the world in both efficiency and equity, thanks to Medicare. But Medicare was established over 40 years ago. It is now a bits and pieces operation – some parts added in good times and with cut-backs in difficult times. Some additions have been made by Labor governments and some by anti-Labor governments. There is little coherence or consistency in what we have at the moment. Our health care arrangements could not be called a ‘system’. They have no clear and underlying principles or philosophy.

    As a result of that lack of coherence and fragmentation there is waste in our health care arrangements. Nurses, doctors, paramedics and others are all working hard and professionally, but there are managerial inefficiencies and high bureaucratic costs in both the private and public sectors: I have estimated that reforms would result in a saving of at least ten per cent of our health bill or about $15b in today’s costs. Abolition of the taxpayer subsidy of over $7b per annum to private health insurance would represent about half of these savings.

    But a big waste is in misallocation of scarce resources. Capacity to pay often overrides consideration of therapeutic needs. Governments seek savings in public health and primary care – savings which are more than offset by higher needs for hospitalization and high cost specialist care. Demarcation rigidities result in overwork for some and under-utilisation of skills for others such as nurses. In all, the whole is far less than the sum of its parts.

    Seldom do we stand back and ask the central issue: what do we need and expect from a health system? That question should be a starting point for reform.

    The concerns of health policy – a system approach

    Incremental reforms addressing real or perceived shortcomings in particular programs, even if they achieve some economies, are going to do no more than to perpetuate existing problems. Reform needs to cut across programs, and concerned with the following six issues.

     

    1. Primary care. Primary care has been largely ignored in health reform. It should be the starting point for any consideration however of preventive health and chronic care. Early interventions and health check-ups can head off costly and debilitating illnesses.

    Specialist care has become very expensive. We have an obsession with hospitals. But hospitals should be the last resort rather than the first. Countries such as the United Kingdom and New Zealand have high quality care in part because of the philosophy underlying their systems, but also because those systems are grounded in primary care, which is the most efficient and equitable way to deliver health services for all regardless of income. It is where care is best integrated.

    Fee for service (FFS) remuneration in primary care has encouraged “turnstile medicine”, excessive treatment and increasingly the corporatisation of general practice.  FFS is a major barrier to reform in primary care. FFS may be appropriate for episodic or occasional care for walk-in patients but it is not appropriate for chronic and long term care, particularly mental and indigenous health care. Our governments have failed in this key area.

    A major barrier of course to improved health services through primary care is that the Commonwealth funds GPs and other medical services, other than those in public hospitals, while the states operate public hospitals. There are substantial savings in keeping patients out of hospitals but with different funding steams there are few incentives to do so. In fact, when the Commonwealth is more concerned with its fiscal balance than with sound economics, it has every temptation to skimp on primary care, essentially imposing higher costs on the states and poorer health outcomes on the community. The Commonwealth’s fiscal obsession has outweighed any sense of economic responsibility

    2. Workforce. Health is the largest and fastest growing sector of the Australian economy. Its structure and workforce are riddled with 19th Century demarcations and restrictive work practices. For example there are several hundred nurse practitioners in Australia when there should be thousands, performing routine functions such as administering regular vaccinations. About 10 per cent of normal births in Australia are delivered by midwives: in New Zealand that figure is over 90 per cent.

    We don’t have a shortage of doctors so much as a misallocation of doctors. Nurses, allied health workers and ambulance staff are denied opportunities to upgrade and realise their professional potential and improve services.

    Pharmacies should be providing more basic health services for the community and should be active partners with doctors in the front line. Pharmacists are the most underutilised and highly-qualified professionals in our health sector. They need to be integrated into primary health care.

    There will never be adequate delivery of service to people, particularly the aged, without radical workforce reform, mainly within primary care. As Minister for Health, Nicola Roxon enabled some nurse practitioners and midwives to access the Medical Benefit Scheme but the access was quite minor. The MBS can be the lever for major workforce renewal.

    It is quite remarkable that we have endless talk about the need for workforce reform everywhere but in the health sector. Surely governments could not be frightened of the AMA! In our modern economy the restrictive work practices and demarcations in the health sector are a disgrace.

     

    3. Program structures. Health services are structured and funded around providers – medical services by doctors, pharmaceuticals through big Pharma and the Pharmacy Guild, and hospitals through state governments and private agencies. The structure of the Department of Health and Ageing reflects this provider focus rather than a focus on consumers.

    Such a provider-based structure, rather than a user- or customer-based structure, is reminiscent of corporate structures abandoned in the private sector a half-century ago, and is inconsistent with the “outcomes” focus of public sector reforms of the 1980s. Yet it survives in the health sector with the only institutional recognition of consumers is through the Health Consumers Forum of Australia, a body funded by the Commonwealth and which seems more like a marketing arm of the Department of Health and Ageing than a group representative of consumer interests.

    We need to progressively change the focus of health programs to serve the community rather than providers. One possible structure would be around types of users – acute, chronic and occasional. It would help reduce the competition between different provider areas for limited resources. The Department of Health and Ageing shows no serious interest in consumers but together with the Minister always seems to have an open door for the rent seekers such as the Pharmacy Guild.

     

    4. Funding. Funding of health services is a mess, resulting in serious inequities, high administrative costs, and misallocation of scarce resources. Some services, financed either through private health insurance or Medicare, are free at the point of delivery, while others can leave consumers with massive out-of-pocket expenses.

    We have some of the highest co-payments in the developed world but they lack rhyme or reason. They are a “dog’s breakfast” with the level of government subsidies varying enormously. Some co-payment arrangements work on a safety-net basis, while others, such as for psychologists, leave the consumer bearing open-ended risks. The Abbott Government’s “reforms”, if implemented, would make the situation worse. Medical and pharmaceutical co-payments have little in common, and dental services are much more poorly funded than medical services. The safety nets are unfair and lead to abuse.

    Persons on high incomes should pay more for health services through efficient and defensible co-payments. A “universal” service does not necessarily mean it should be free. Subject to a means test, there needs to be more discipline by consumers in their use of health services. Jennifer Doggett at the Centre for Policy Development has proposed workable means-tested reforms in this area with a Health Credit Card. See http://cpd.org.au/2009/07/out-of-pocket-rethinking-health-copayments/ There is no sign the Commonwealth is concerned about the problem however, even though most other countries have better models to emulate. The Nordic countries, for example, insist on a single public funder and universality but with efficient and equitable co-payments.

    The other great funding distortion in Australian health care arrangements is private health insurance (PHI) – essentially a high-cost mechanism which allows some, particularly those with high incomes, to jump the queue for health services, thus worsening waiting times in public hospitals and diverting resources to private hospitals, contrary to the claim that it takes pressure off public hospitals.  It penalises country people because there are few private hospitals in the bush. Australia’s arrangements also mean that private and public hospitals operate on different funding streams and with little integration of services.

    The government, through means testing rebates for PHI, has removed some inequities, but PHI remains a costly and inequitable way to do what the tax system and Medicare do much better. Also, PHI is administratively inefficient with bureaucratic costs about three times higher than Medicare.

    Private gap insurance promoted by PHI has facilitated enormous increases in specialist fees. Most importantly, the expansion of PHI progressively weakens the ability of Medicare to control costs. The evidence world-wide is clear that countries with significant PHI have high costs without any better health outcomes.

    The stand-out example of PHI causing high costs and poor outcomes is the United States.  President Obama may have substantially achieved universal coverage, but PHI with its lack of cost control will ultimately cripple and finally destroy his reforms. Warren Buffett has described PHI companies as the “tape worm” in the US health sector.

    The Commonwealth already has a sound model of a single payer operated through the Department of Veterans Affairs – a model which retains the strong control of a single payer accountable to the community whilst allowing private practise involvement in service delivery.

    The Commonwealth has failed to understand the damage that PHI is already doing in Australia. PHI is a Damocles sword hanging over Medicare. We must assert the key importance of a single public funder.

    It is interesting to note that the $7b plus per annum taxpayer subsidy to PHI is more than would be required to fund a Medicare dental scheme!

     

    5. Defining Medicare. This great Labor monument needs a review. Medicare has become a passive but efficient funding mechanism, providing a partial subsidy for certain health expenses, rather than the public insurer it was intended to be. After all, it is still called the “health insurance commission”, but it is nothing of the sort, and it is not even within the health portfolio.

    Medicare has a remarkable database which should be used to highlight and inform policy concerning over and underutilisation of services across the country. Why for example do rates of caesarean section vary enormously across the country and why are Australian rates very high in world rankings? There are many other large variations in clinical procedures that must be made public and explained.  Medical services should be subject to the same rigorous cost-benefit examination as pharmaceutical services. Medicare is not doing it.

    Even more potential lies in the use of that database for research into efficacy of treatments. This was an intention of Medicare’s designers, who envisioned the day when computing power could extract clinical information from that database. That day has arrived, but the government, although willing to invest billions in some areas of medical research, shows no interest in using this valuable resource, or in the integration of MBS and PBS data which would provide rigorous pharmaceutical evaluation at a tiny fraction of the cost of clinical trials.

     

    6. Cost and blame shifting. Governments, more concerned with their fiscal balances than with economic efficiency, try to shift costs on to other governments, Commonwealth to state and vice versa, on to individuals, or on to future generations for example in neglect of public health. Attempts to resolve the Commonwealth/state blame and cost shifting have been largely unsuccessful and certainly expensive with the Commonwealth succumbing to state political pressure without fixing the lack of integration.

     

    In Part 2 I will be looking at the major obstacles to health reform, including the influence of the vested interests who are concerned to protect their own territory rather than serve the public interest.

  • John Menadue. Health Workforce Reform.

    Conservative commentators and the Business Council of Australia speak endlessly about the need for industrial and workforce reform particularly in the blue-collar area where there has already been very substantial reform and improvement. Changes in the Australian workforce have helped transform the Australian economy in the last 30 years. It was begun under the Hawke/Keating governments and continued under the Howard governments.

    But the health sector has scarcely been touched. I ‘guesstimate’ that there is a potential productivity dividend of at least 40% in health workforce reform over the next decade. That 40% may be on the low side. The Productivity Commission estimated a few years ago that a 10% efficiency improvement in health would deliver an $8 b dividend at that time.

    Reform of the health workforce structure, work practices, multi skilling, teamwork, and flexible training, are the key micro-reform issues that we face.  The most obvious example of restrictive practices in health is in obstetrics and midwifery.  In Australia, less than 10% of normal births are managed by midwives.  In the Netherlands it is over 70% and in the UK over 50% In NZ it is 90%.  The reason why Australia is so far behind the field is opposition by obstetricians who want to protect their market share and high incomes. They are highly favoured through the Medical Benefits Scheme.

    Health is Australia’s largest industry, and employs about 7% of the civilian workforce.  About 70% of every health dollar of expenditure is in labour costs. Such a large area of expenditure cannot be excluded from workforce reform. It is more important than any other workforce issue. Health workforce reform will not be easy but it is essential. Above all else it requires political courage to face down the special and entrenched interests that dominate the health sector.

    Several years ago, an emeritus professor at University of Sydney, Professor Kerry Goulston described the problems he saw as follows.

    Our medical workforce management in hospitals is rigid and antiquated. Job sharing is rare. … Most hospitals are staffed on the front line at nights and weekends by junior medical staff, often without onsite supervision…. The traditional roles of doctor, nurse and allied health personnel have to be redesigned around the patients’ needs.  Many procedures carried out by doctors could be done by non-doctors. Many medical duties could be done by other health professionals. In places where it has proven impossible to recruit doctors, nursing staff have been upskilled to provide a higher level of clinical care. It is clearly possible to extend this model for use in public hospitals where better supervision is available, but would require a reduction in the strict demarcation of clinical roles. … The morale of our hospital workforce is low. Disengagement and loss of commitment is a real issue.

    We clearly need to dramatically reshape our health workforce. The Productivity Commission made the first serious attempt to address the problem. But progress has been very slow.

    My own view is that the financial lever of the Medical Benefits Scheme is the best way to promote reform. Nicola Roxon made a few changes in this regard but it was quite minor.

    We need concerted and strong political and administrative action to break down  the old historic workforce boundaries and boxes and  establish new ways of working – teams working across professional and organisational boundaries; flexible working to make the best use of the range of skills and knowledge of staff; streamlined workforce planning and development which stems from the needs of patients not of professionals; maximising the contribution of all staff to patient care, doing away with barriers which say only doctors or nurses can provide particular types of care; modernising education and training to ensure that staff are equipped with the skills they need to work in a complex, changing health system; developing new, more flexible careers for staff in all professions; expanding the workforce to meet future demands and more flexible deployment of staff to maximise the use of their skills and abilities.  .

    We need for example to consider nurses undertaking greater responsibility for prescribing, diagnosis and triage in hospitals; nurse anaesthetists complementing and substituting for medically qualified anaesthetists; enrolled nurses taking on some of the tasks currently done by registered nurses; midwives substituting for obstetricians; new allied health assistants supporting allied health workers to increase their capacity to treat more patients; practice nurses undertaking some of the work currently performed by GPs, including some prescribing, screening and triage.

    Professor Peter Brooks  has drawn attention to the 60,000 physician assistants in the United States who grew out of the ‘medics’ in Vietnam. They are trained for about two years in 100 professional programs across the United States, concentrating on science and clinical aspects.

    Clearly nurses, allied health, ambulance officers and community health workers could undertake more skilled work except for the barriers erected by other professionals.  Pharmacists need to employ their professional skills in primary care with less of their time spent as shop keepers.

    The great problem is that our health and community services workforce is trained and works in boxes – ‘there are boxes everywhere’. We need dramatic change, up-skilling, multi-skilling, broad banding and teamwork.

    Failure to tackle these major workforce problem results in clear loss of morale and high staff turnover across the health and community sector. We see the problems like the tip of the iceberg, only when they are revealed before a court or medical board. The powerful sectional interests still call the shots and resist change. If they had blue collars, rather than white coats, the story would be different.

    What is lacking is courage and determination to address the problem. Excuse me dropping names but in the late 1980s, I attended a round table discussion with UK Prime Minister, Maggie Thatcher in Sydney.  She was asked ‘now that you have reformed the work practices of the printers and coal miners in the UK, what do you propose to do about the restrictive practices of doctors and lawyers?’  She replied, ‘It is a very serious problem, but if you don’t mind I will leave it until my last term’.  The coal miners and printers were fair game, but not the doctors and lawyers who were put in the ‘too hard’ basket.

    The health and community workforce structure is at the end of its design life. The whole health system is built around provider demarcations. It must be efficiently built around patients’ needs.

     

     

  • Nanny Endovelicus. Preventing prevention Part 2

    This is part 2 of a series on health prevention. It was initially posted in October last year.  John Menadue.

    Yesterday, in part 1, I began the task of analysing the cuts to the Commonwealth’s health budget and to the promised payments to the States and Territories in the area of prevention. Are the cuts well justified by the statistics?

    Obesity – Nutrition and Physical Inactivity

    Other than tobacco and excess alcohol consumption, the rising rates of obesity are the most concerning statistics in the area of preventable diseases. People’s diets and their levels of physical activity both contribute to obesity and overweight. By mid 2012, almost two thirds of Australians over 18 years were either overweight or obese according to the Australian Bureau of Statistics, a significant increase from a decade ago. The current combined level for obesity and overweight is 63% for adults (70% of men and 56% of women). Of children between the ages of 5 – 17, about 18% are overweight and 8% are obese; this is very bad news, but at least it isn’t worse news – these numbers for children are largely unchanged since 2007-08. Unsurprisingly, a clear pattern of socio-economic disadvantage is visible: the prevalence of obese children, for example, is four times higher in disadvantaged areas.

    Australia is now in the top league tables in the obesity stakes, still lower than the United States but we’ve been catching up fast.

    On specific metrics for exercise and nutrition, the AIHW (Australian Institute of Health and Welfare is also being abolished as a standalone statutory body by decision of the 2014 Budget with the functions to be amalgamated in a mega ‘productivity and performance’ entity) reported this year that: 92% of Australians did not eat 5 serves of vegetables per day and 52% did not eat 2 serves of fruit; and only 43% of adults were active enough to meet recommended guidelines of 150 minutes per week of walking or other moderate or vigorous activity.[1]  

    The nation has a long way to go on the obesity problem. Dutton often cites the alarming obesity statistics – but mainly as a precursor to argue for his plans to charge people more for primary care from their GP – which is of course where a lot of prevention advice is given and where lower-income people are most likely to go. Given the current minister is well aware of the problem, presumably there are major initiatives to tackle obesity. However, there is no evidence in the federal budget of anything much being done. Perhaps the government is making good on its comment that this is a matter for people’s personal responsibility.

    Other Risk Factors

    There are of course other risk factors both behavioural and biomedical – eg. high blood pressure, high cholesterol, high salt intakes – but it is in particular the key risk factors described above which drive the major increases in chronic disease.   So while not unimportant, the Commonwealth, States and Territories chose to focus their efforts and funds on the SNAP behavioural risks that could potentially be influenced in a better direction.

    Where to now?

    So, with the data under our belts, does the picture suggest less attention or a reduction in funding for prevention activity?  The answer is self-evident.  More emphasis on prevention is clearly in order.  And that is what most countries are doing – increasing considerably their attention to the difficult area of lifestyle risk factors in order to counter the significantly increasing burden of preventable chronic diseases. The head of the World Health Organization, Margaret Chan, has noted that chronic noncommunicable diseases have overtaken infectious diseases as the leading global cause of morbidity, disability, and mortality and stated that “prevention must be the cornerstone of the global response.” So what’s going on in Australia? Why this attack on lifestyle-related prevention activity.

    There are perhaps two interrelated answers.

    That the Abbott Government is proving to be highly ideological – not a feature of their campaigning before the election – is hardly a matter for debate any longer.  The extent of the ideological thrust is however a surprise to many as is the extent of the influence of the far right think tanks like the Institute of Public Affairs. The IPA had waged a highly visible campaign against nanny state prevention activities in the election lead up. During the Budget, the ideological tenor of the government was especially on display when increasing spending. More money for medical research! Terrific idea? In principle, you’d think so. But the funds are for Medical – big M – research; Dutton made clear that it’s a Medical Research Future Fund – not a Health Research Fund – which is far more likely to rule out research into, for example, factors influencing behavioural elements like fast food or alcohol consumption. Particularly ironic (depressing) – but sending the clear ideological message – the savings from killing off the COAG Preventative Health Partnership and abolishing the national Prevention Health Agency are being directed into the Medical Research Future Fund according to Budget Paper #2.

    Just as worrying, and well documented by others, is the influence of the alcohol and food industries on the government (see for example Big Food with a regional flavour – how Australias food lobby works). The embarrassing Fiona Nash’s behaviour in hiring a junk food lobbyist as her chief of staff was probably just the visible tip of a very large iceberg. Her hamfisted attempt to delay the website and possibly wipe out the food star labelling system – and this is a voluntary system for the industry! – created the first scandal for the then new government. Given the level of control over ministerial staff appointments out of the PM’s office, one could suppose the PM thought there was no problem with having a junk food voice so intimately involved in the food minister’s work — a supposition largely confirmed in his refusal to have his non-performing junior minister resign over the matter. (As an aside, however, his reluctance could well be compounded by that fact that there are rather few women in the ministerial club and losing one – and a Nat at that – might have been rather problematical). At least they don’t let Nash out in public very often – although her launching of the most recent phase of the national tobacco campaign from a party base that still accepts Big Tobacco funding had a number of us seriously exceeding the NHMRC alcohol guidelines for single occasion risk!!

    Where the industry influence and the ideology will take us eventually is probably not to better health outcomes. Cuts to areas like prevention, just like undermining investment in newer green technologies, do not have outcomes that are immediately visible – the negative results take some time to manifest.   Eventually, our performance or rather lack of it, in prevention will become evident in the burden of disease measures and in comparison with other countries who are diligently tackling the tough lifestyle issues. The actions of an ideological government, out-of-touch with international evidence and action on these matters, is not likely to serve Australia’s longer term interests.

    [1] Australia’s health 2014, AIHW

  • Nanny Endovelicus. Preventing prevention. Part 1

    This repost is an outstanding article on prevention that I originally posted in October last year. Part 2 will follow tomorrow.  John Menadue

     

    One of the more curious decisions of the Abbott Government in its 2014 Budget was the decision by Health Minister Peter Dutton to reduce Commonwealth expenditure on prevention.

    Funding for population health broadly is set to decline substantially – although the brunt of the cuts are for later years and the real devil is in the finer detail.

    For the Commonwealth Department of Health in Outcome 1 – Population Health, the pain in the first full Dutton year is minimal – a decrease from $167M in 2013-14 to $166M in 2014-15 – peanuts! But even in this set of numbers, there are interesting messages. Prevention includes activities that “look like” medical work, for example immunisation and cancer screening programs. These areas were largely protected.

    But prevention also includes the more difficult and contentious health promotion tasks – regulatory policy for alcohol and tobacco and food (which requires examining industry behaviours like advertising of junk foods, salt levels used in processed food, and alcohol promotions) as well as programs targeting people’s lifestyle choices in areas such as smoking, alcohol use, physical activity and eating habits. As we saw last week with Liberal Democrat Senator David Leyonhjelm’s outburst on “excessive’ smoking taxes and his right to accept Big Tobacco donations, these lifestyle messages and the regulation of these industries in the interests of population health is political by definition and is likely to be an anathema to libertarians and the hard right. The imagery reached for is that of a ‘nanny state’ – see the Institute of Public Affairs (another recipient of Big Tobacco largesse) for a detailed exposition of the position.

    It is this latter area of work that took the real Budget hit.

    Programme 1.2 of Outcome 1 (for us non-bureaucratic mortals this is the part of the budget dealing with drugs like alcohol, education against illicit drug use, and tobacco) was reduced from $224M in 2013-14 to $161M in 2014-15.   And it goes on. This area will be further reduced to $131M by 2017-18 according to the forward estimates – a decrease in nominal terms of over 40% – while some of the other population health activities actually see some modest increase in that period. The axe is being swung not only at the federal level. With the Dutton death blow to the COAG[1] Partnership on Preventative Health, some $400 million of promised funding for the State and Territory Governments’ lifestyle prevention initiatives were axed as well – programs in particular focussed on children’s physical activities, community exercise and nutrition initiatives, education about lifestyle related risks and so on.

    Is there good logic to this – why cut prevention rather than, for example, reducing funding for some of the 150 low-value medical interventions that have been identified?[2]  Had the need for work in prevention lessened?  Were the metrics now moving so clearly in the right direction that government could turn its attention (and money) elsewhere? Almost all other developed countries had also been significantly increasing their attention and expenditure on prevention in the 21st century, were they cutting back too?

    SNAP – but no crackle and pop

    In 2011, the primary driver for establishing the National Partnership on Preventative Health was the alarming increase in preventable chronic disease related to people’s lifestyles.  These lifestyle issues – in particular Smoking, poor Nutrition, Alcohol misuse and Physical inactivity – the SNAP lifestyle risk factors – already accounted for some 40% of potentially preventable hospital admissions according to the Australian National Preventive Health Agency (not just a cutback but abolished in the 2014 Budget).   The growth of lifestyle diseases worrying those watching health expenditure were primarily in diabetes, various cancers, COPD, strokes and other preventable cardiovascular system diseases.

    Let’s check how the SNAP risk factors are doing.

    Tobacco

    Tobacco reduction strategies are the star performers on a population basis – a national decrease from about 35% in 1980 to 16% in 2012.  That’s one of the lowest adult smoking rates in the world.  But with some big holes. The COAG Reform Council, whose job was to assess performance of governments against their stated targets (the Council was also abolished in the May 2014 Budget), reported on the performance of the Preventative Health Partnership in 2013 and noted that Indigenous smoking rates were much higher than those of the rest of the population – still over 40%. Also important were socio-economic factors – if you are in the lowest socio-economic demographic, you have a 25% likelihood of being a smoker as compared to a someone in a more advantaged situation. Further, the city-country divide is extraordinary.  The National Health Performance Authority (to be abolished as a standalone statutory body by decision of the 2014 Budget with the functions to be amalgamated in a mega ‘productivity and performance’ entity) reported in October 2013 that in areas such as the Grampians, smoking rates were 28% as compared to city areas such Inner West Melbourne where the rate was 8%. In general, on most of the risk factors for chronic disease, the further from the city you live, the less healthy you are likely to be![3]

    While overall population figures might suggest that smoking is largely ‘done’, what the more granular data suggest is that success has been high in higher-income higher-educated urban populations and that significant effort is needed elsewhere where rates look like statistics from 30 years ago. Some focused attention was in fact occurring, in part. A major initiative – Tackling Indigenous Smoking – spearheaded by Tom Calma – was rolling out across Australia; it has had its expansion “paused” to undergo a review of its efficiency during 2014. One note of optimism: although not quantified in terms of expenditure, the May 2014 Budget committed to continue Australia’s defence of the plain-packaging of tobacco cases brought within the WTO and bilateral trade treaty arrangements.

    Alcohol

    There’s good news and bad news on alcohol. The evidence about alcohol as a risk factor has been mounting, and it’s a Group 1 carcinogen (ie good evidence it’s harmful to humans). This led a couple of years ago to a tightening of the guidelines from the NHMRC on alcohol consumption (the NHMRC is a medical research funder – and medical research is Abbott’s favourite thing – so it wasn’t significantly cutback, planned to be amalgamated or otherwise mauled in the Budget apart from the plan to set up a duplicating bureaucracy in the new Medical Research Future Fund).

    Harmful consumption of alcohol has two forms – long-term consumption at risky levels and single occasion risky consumption (basically binge drinking).   Latest stats are that about 20% of the population continues to drink at levels risky to their long-term health – pretty well unchanged from the ABS results in 2007-08; half of males and one-third of females drank riskily for single occasion risk. These are quite high statistics at a population level. The good news is that since the 1970s, our per capita alcohol consumption has declined although it remains above the OECD average.

    By far the most concerning SNAP areas are the ones leading to the disturbing trends in obesity and overweight. Both nutrition and physical activity contribute to obesity – more on the statistics and their implications in the next blog tomorrow.

     

    ***************

    [1] Council of Australian Governments

    [2] Elshaug AG, Watt AM, Mundy T, Willis CD. Over 150 potentially low-value health care practices: an Australia study. Medical Journal of Australia, 20212; 197(10): 556-560.

    [3] Risk Factors Contributing to Chronic Disease, AIHW, 2012.

  • John Menadue. Co-payments and the government’s attack on general practice.

    You might be interested in this repost.  

     

    A strong primary health care system based on general practise is the key to a sustainable health service. Unfortunately the government is doing its best to weaken general practice.

    Primary care offers the best prospect of improved quality of care and increased efficiency, particularly through new work practices. The evidence is worldwide that primary care provides

    • A greater focus on prevention and chronic care for our ageing population.
    • Care at lower cost e.g. specialist care in Australia is more than double the cost of care by a general practioner.
    • Faster medical treatment
    • Consolidated service delivery to overcome fragmentations.
    • A seamless one-stop approach
    • Consolidated history with test results
    • Better access for all.

    Primary care reform is the single most important strategy for improving our health and making the health system sustainable This is true for all countries, developed and undeveloped..

    Community level prevention and primary care is essential to restoring universality and efficiency in Australian healthcare. Further, health services should be delivered at the most local level possible – the principle of subsidiarity.  The dignity of patients is best safe guarded by treating patients in their homes or as close to their homes as possible.

    Hospitals should be the last resort. They are very expensive. A visit to a hospital emergency department costs ten times the cost of a visit to a GP. Too often politicians, the hospital lobby and the media keep telling us that hospitals and hospital beds are the top priority. They are not.

    We need to improve general practice rather than weaken it as the government is doing. At the same time we need to review the way doctors are remunerated. Fee-for-service puts up costs and discourages integrated care. The government should consider two possible changes. The first is that the MBS schedule be amended to permit private practices to remunerate a supervising general practitioner in their practices. That supervising GP would be remunerated for over-sighting the treatment and referral of patients and their records. The second is that the government should offer to negotiate contracts with practices, both corporate and non-corporate, that will commit to the delivery of integrated care. I expect that the government would be agreeably surprised at the number of GP practices that would respond because of their concern about the ‘turnstile’ nature of a lot of general practice in Australia today. Doctors should be remunerated for keeping patients healthy rather than remunerating them when their patients are sick. What a perverse incentive we have in FFS!

    A related key to a sustainable heath system is health workforce reform, particularly in primary care. We have tens of thousands of health professionals whose skills are underutilised or undeveloped – nurses, allied health, pharmacists and ambulance officers. About 10% of normal births in Australia are managed by midwives. In NZ it is over 90%. We have about 400 nurse practitioners when we should have thousands. The medical colleges have disproportionate influence in controlling access to the professions.  Medical training is strongly focused on acute care in hospitals, whereas most of the work of future doctors will be with chronically ill patients in the community. Few are trained to work in team practices. Primary care is not seen as an attractive option for young doctors. Only 13% of final year students have any interest in working in primary care, and only 13% would consider working in rural areas. General practice must be made more attractive and better paid compared with specialist care, but not via fee-for-service.

    Our health sector is wracked by nineteenth century work practices. It is the largest part of the Australian workforce. It is the fastest growing. We are regularly told that we need to improve the productivity of the Australian workforce. But the largest part of the Australian workforce in the health sector is not mentioned. We have seen the dramatic benefits in productivity improvements through workforce reform in many areas. But those gains are small beer compared with the potential gains with health workforce reform, leveraged by such means as wider access to MBS and making all Commonwealth health funding conditional on substantial workforce reform.

    We need substantially improved health work practices to improve the efficiency of our health sector and to lower health costs. It is also necessary to expand the professional opportunism for tens of thousands of health care workers.

    But workforce reform is hard because the AMA is determined to protect the territory of doctors in the name of quality and safety in health care.

    The key to a sustainable health system is in primary care and general practise associated with workforce reform. But the government is undermining general practise and talks endlessly about the need for workforce reform but is not game to tackle the vested interests in the health sector.

     

  • John Dwyer. Medicare changes – why on earth would a young doctor want to be a GP?

    In case you missed it, this is a repost of a blog that I posted on 12 December last year.  It is highly relevant to the continuing debate about copayments and general practice.  John Menadue.

    The most distressing feature of the government’s determination to have us pay more for a visit to our GP is its the total lack of vision for the structural reforms we should be discussing to provide Australians with Primary Care services that meet contemporary needs, are equitable and more cost effective. Instead of focussing on new models of care that around the world have been shown to achieve better health outcomes than we enjoy in Australia, the  $5 reduction in the remuneration for a standard GP consultation will make matters worse. The logic associated with this latest initiative is seriously flawed. Placing the money saved into a research fund means that the proposed reduction will do nothing for the budgets bottom line, the imperative presented to us in the May budget.

    The Government wants to send a “price signal” to Australians to remind us that no longer can we expect Medicare to be free. Australian taxpayers provide every cent of the 19 billion dollars we spend each year on Medicare. If you pay to join a tennis club but do not pay extra for having a game of tennis you don’t consider that game to have been free. There is in fact plenty of evidence that current additional expenses associated with Primary Care see many delay seeking help and unable to afford prescribed medicines. Our out of pocket expenses for health care top 29 billion dollars a year, on a per capita basis, second only to the United States.

    Australians on average, make five visits per year to a GP.  That does not suggest that we are abusing our entitlement to Primary Care services such that we need to be discouraged from visiting our doctor. With health expenditure at 9.3% of GDP there is no health budget crisis and there is time to make structural reforms that would achieve better outcomes and continue to make our expenditure sustainable.

    The truth is that many of us need to visit a GP more frequently if we are to avoid the pain and suffering associated with chronic disease, the problem that is eating up the majority of our health care dollars. Many rural Australians, whose health outcomes are disgracefully inferior to those of their city cousins, would willingly consult a GP more frequently if there were GPs to consult. If Rural Australians accessed Medicare funded services as frequently as urban Australians the cost to Medicare would be an additional two billion dollars.

    The future availability of sufficient numbers of general partitioners is already problematic. Only 13% of young doctors express any interest in becoming a “GP”. Only one percent are contemplating a career as a rural GP. Primary Care training is rigorous and GPs are true specialists. How does all the rhetoric from Canberra about the pivotal role they play sit with the proposed $31 fee for a standard consultation? Given the training required and the responsibility associated with medical care this fee is frankly insulting. The discrepancy in the income potential for GPs when compared to that of other specialists is now huge. No wonder young doctors considering career options are increasingly ruling out Primary Care. The ability of GPs to consider “bulk billing” the majority of their patients is only possible if the total remuneration they receive is satisfactory. Bulk billing doctors will not be able to absorb the five-dollar cut in the Medicare rebate and are appalled by the added levels of bureaucracy and paper work that the new arrangements will entail.

    Young doctors looking at the professional life of our GPs are uncomfortable with the current “fee for service” model which encourages “turnstile” medicine that is so professionally unfulfilling. Many GPs join corporate Primary Care providers preferring a salary. In New Zealand the government has facilitated 85% of the nation’s GPs moving away from “fee for service” payments. The same is true for 65% of US Primary Care physicians.  Throughout the OECD health systems recognising the perverse incentives associated with fee for service remuneration are exploring changes that increase a GP’s remuneration for keeping people well.

    Were it not for the destructive division of health care responsibilities shouldered by State and Federal governments, Canberra would not be looking at Medicare as if were in isolated from the rest of the health care system. Hospital expenditure, at more than 50 billion dollars per year, dwarfs Medicare spending and is increasing more rapidly. There is now abundant international evidence that we should be spending more on Primary Care services to reduce the spiralling cost of hospital services and at the same time achieving better health outcomes for the community. Just this week the UK government has been presented with a review that concluded that an extra 72 million pounds spent on improving Primary Care in the community would save the system 1.9 billion pounds by 2020! The future of quality hospital care in our country is totally dependent on reducing demand for hospital services through better Primary Care.

    A competent government would be looking at the way we can introduce the highly successful “Medical Home” model of Primary care where teams of health professionals populate a practice and are available to enrolled patients. The infrastructure is available to help people avoid illness, have potential problems recognised earlier, offer coordinated “in house” care for people with chronic problems and care for many in the community currently sent to hospital. But no, all we discuss is this five-dollar impoverished initiative. The Abbott government should abandon this latest plan and start a dialogue with health professionals and the community about needed structural reforms that would extract far more health from the available dollars.

     

    Professor John Dwyer is Emeritus Professor of Medicine UNSW.

  • Mary Chiarella. Co-payments, general practice and workforce reform.

    If there’s a problem in primary health care then nurses are (and always have been) the solution. 

    Susan Sontag wrote in 1978 “Illness is the night side of life: a more onerous citizenship. Everyone who is born holds dual citizenship, in the kingdom of the well and the kingdom of the sick”. I was working in palliative care nursing when I first read this and it struck me that, continuing the metaphor, nurses were therefore like tour guides for those negotiating these health care kingdoms of both the well and the sick. We provide the translator services (“what did they say nurse?”), the coordination of meetings and events (“I need an appointment to see…”); the advice on what to do and how to do it (“I don’t know how to work this spacer thing”), and always, always, always the assistance to do whatever needs to be done when people lack “the necessary strength, will or knowledge” (Henderson, 1966) to do it themselves.

    If we look to primary health care (PHC) there is clearly a need for “tour guides” in this space, whether it be to help them stay in the kingdom of the well or to assist them to travel in the kingdom of the sick. John Menadue has suggested the key is to rethink funding for general practice. I would go further. The key is to rethink who provides the bulk of PHC and then think about how to fund it.

    In 2009 I compiled a compendium of nurse-led PHC models in 38 countries for the World Health Organisation (WHO, 2009).The elements of PHC identified for reporting purposes in the template were that each service, programme or project should:

    • provide essential health care based on practical, scientifically sound and socially acceptable methods and technology;
    • be universally accessible to individuals and families;
    • involve full participation of the community;
    • have a cost that the community and country can afford to maintain;
    • foster self-reliance and self-determination;
    • be an integral part of the country’s health system and overall development; and
    • have an entry level for patients located close to the heart of the community.

    The main needs of the populations served were those of the chronically ill and the elderly, basic social and infrastructure needs, psychological and mental health needs, maternal and child health needs and acute care needs (particularly in war zones).

    To provide a local example of what is possible, the work of an Aboriginal renal nurse practitioner in Australia with both indigenous and non-indigenous groups suffering from end-stage renal disease brought about significant health gains. The need for this role was identified as a result of the rising number of people needing acute dialysis 24 hours a day. A retrospective study of the causes of this rise suggested that 80% of the patients had risk factors that, if addressed early enough, would have prevented admission to the tertiary referral hospital for acute intervention. These risk factors were further examined and the diagnostic, clinical and referral skills required to address them were evaluated, and it was found that the scope of practice of a nurse practitioner met the requirements. The community nephrology nurse practitioner was able to develop and implement nursing models that integrated evidence-based clinical management with nursing advocacy for quality of life.

    Two key areas, considered central to the success of the case studies, presented challenges for a number of contributors. These were the issues of reliable and adequate funding and resources, and challenges to narrow thinking about the capacity of staff to take on new roles. The issue of sustainable funding; access to other resources such as medication, equipment, textbooks and staff created significant challenges. Some projects were completely or predominantly funded through the charitable sector (for example Chile, Haiti, United States). For example, a US project working with a poor community in Chicago sought its primary funding from a charity, and supplemented it with grants from no less than 16 funding sources and a further 13 in-kind donation sources. The time required to undertake the fundraising, administration and reporting on so many donations takes the nurses away from much-needed care delivery.

    In addition, there were a number of reports of medical and some nursing staff having difficulty in letting go of conventional and stereotypical thinking about who ought to perform which tasks. This issue has been much studied and discussed (Chiarella 2002) and has been described in relation to affirmative action as the ‘myth of the meritocracy’ – the possibility of work being taken on by another group, unless similarly qualified, is unthinkable because they are seen as incapable of meeting the challenge (Hall 1997). Yet there is ample evidence and experience to show that different personnel and community members are capable of equal, high quality participation in health care decision-making and delivery. Strong claims to maintain the status quo are often made on the grounds of safety and quality, but the evidence about the outcomes demonstrates this resistance to change is based only on protecting professional power and privilege.

    There is such potential to harness the skills of nurses to provide first class primary health care in this country, yet currently we seem to move further and further away from this potential and back to outdated models of health care provision that service only those who can afford to pay.

    Mary Chiarella is Professor of Nursing, Sydney Nursing School, University of Sydney.

  • Luigi Palombi. It’s time to fix the free trade bungle on the cost of medicines.

    Ten years on from the Australia-US Free Trade Agreement, Australia is entering another round of negotiations towards the new and controversial Trans-Pacific Partnership. In this Free Trade Scorecard series, we review Australian trade policy over the years and where we stand today on the brink of a number of significant new trade deals.


    Negotiations for the Trans-Pacific Partnership present an opportunity to correct a mistake made a decade in the Australia-US Free Trade Agreement, which led to Australia paying higher prices for pharmaceuticals.

    In July 2004, Tony Abbott, then health minister in the Howard government, issued this statement:

    The price of pharmaceuticals will not rise as a result of the AUSFTA…

    Contrast this to what the Abbott government’s first budget, in May this year, told Australians:

    Over the past decade the cost of the Pharmaceutical Benefits Schedule (PBS) has increased by 80%.

    To be sure, the “price of pharmaceuticals” is not the same thing as “the cost of the PBS”. But since the PBS is responsible for providing medicines to the vast majority of Australians, it is reasonable to infer that a contributing factor has been a rise in the price of pharmaceuticals. It is also reasonable to infer that the AUSFTA is partially to blame for that rise.

    The legislative instrument through which the AUSFTA was implemented is the US Free Trade Agreement Act 2004. The Therapeutics Goods Act 1984 was also amended to require companies seeking marketing approval for a pharmaceutical to provide a patent certificate as part of the Therapeutic Goods Administration’s (TGA) regulatory assessment process.

    The patent certificate must say if the sponsored medicine will “infringe a valid claim of a patent that has been granted in relation to the therapeutic good (being the patented medicine)” in question. It must also notify the patent holder.

    Otherwise known as “patent linkage”, the application for regulatory approval creates a link between a patented medicine and a possible generic substitute.

    The patented medicines are categorised as F1 formulary medicines, which means there is no approved substitute.

    When a generic medicine comes onto the market, these drugs are contained in the F2 formulary. Generic medicines contain the same active ingredient or have the method of production to the patented drug, or they may be similar in terms of its administration, dosage, method of treatment or indication.

    How does ‘patent linkage’ play out in Australia?

    “Patent linkage” provides advance warning to a patent owner, usually the manufacturer of a patented medicine, that a generic medicines’ manufacturer is about to enter the market with a competing and cheaper substitute medicine.

    With the knowledge that a generic medicine will trigger an automatic 16% price drop for the patented medicine – and result in its transfer from the F1 formulary to the F2 formulary – the patent owner applies to the Federal Court of Australia for a preliminary injunction.

    The injunction is normally granted and as a result, the marketing of the generic medicine is delayed by an average of three years.

    This means that the patented medicine stays in the F1 formulary. This affects the pricing of that medicine not only because the price is higher, but also because medicines in the F2 formulary are subject to mandatory price disclosure. This tends to exert downward price pressure on all medicines within the F2 formulary.

    For a generic manufacturer to defeat the injunction, it must mount a challenge to the validity of the allegedly infringed patent. The average cost of patent litigation is about A$5 million and requires a team of specialist patent lawyers, patent attorneys and highly skilled experts.

    In addition to the legal cost, the generic manufacturer is, by effect of the injunction, denied sales revenue for the duration of the injunction – not to mention the opportunity cost it incurs as its workforce diverts attention to the patent litigation.

    Patent linkage refers to the link that regulatory approval creates between a patented medicine and a possible generic substitute.Sarahbean/Shutterstock

    In Australia, legal costs follow the event, meaning that should the generic manufacturer lose, it will also be required to pay a significant percentage of the legal costs incurred by the patent owner in defending its patent.

    So, it is critical that a generic company carefully assess any patent that puts at risk a proposed generic medicine launch. This assessment costs money. And unfortunately, because of differences in patent law around the world, it is impossible for a generic manufacturer to extrapolate the results of a patent challenge in one country to that in another.

    How does it affect medicine prices?

    The longer a medicine remains in the F1 formulary, the higher the cost of that medicine to the PBS. This, combined with the consequences on price once that medicine moves into the F2 formulary, creates a significant incentive for patent owners to stop generic competition.

    Patent owners encircle a valuable patented medicine with a series of “evergreening” patents. These usually apply after the patent (for the active ingredient) has or is about to expire. This can extend patent protection beyond the normal 20 to 25 year period to a period closer to 40 to 50 years.

    Unfortunately, the profit margin for generic manufacturers has fallen significantly due to the price disclosure mechanism, while the cost of patent litigation has risen significantly. Consequently, the capacity of generic manufacturers to assume the risks involved in risky and expensive patent litigation has fallen dramatically.

    In the absence of any serious intervention by the Australian Competition and Consumer Commission, it is likely that fewer “evergreening” patents will be challenged in the future. This means that more medicines will remain in the F1 formulary and for a longer period and the costs of medicines will rise.

    A consequence of price rises, particularly at a time of economic austerity, is that newer medicines are not being listing on the PBS. The Pharmaceutical Benefits Advisory Committee, which decides which drugs will be subsidised through the PBS, for instance, recently rejected the costly drug Sovaldi, despite effectively treating hepatitis C virus infection.

    If the Abbott government wishes to limit the annual cost increase of the PBS to 4%, it is critical that only medicines that are truly innovative and deserving of patent protection remain in the F1 formulary. If room in the PBS is to be made for medicines such as Solvadi, then it is essential for more of the older F1 medicines be moved into the F2 formulary more quickly.

    The cost of the PBS has risen by 80% in the past ten years. It’s likely that without the AUSFTA, the cost of the PBS, and by inference the cost of medicines, would have risen by much less.


    This article draws on research prepared for the 2014 Workshop “Ten Years since the Australia-US Free Trade Agreement: Where to for Australia’s Trade Policy?”, sponsored by the Academy of the Social Sciences in Australia and Faculty of Arts and Social Sciences, UNSW Australia.

    Luigi Palombi is Adjunct Professor at Murdoch University. This article was first published in ‘The Conversation’ on 21 October 2014.

  • Hazel Moir and Deborah Gleeson. Evergreening and how big pharma keeps drug prices high.

    Efforts by pharmaceutical companies to extend their patents cost taxpayers millions of dollars each year. In some cases they also mean people are subjected to unnecessary clinical trials.

    Big pharma makes big profits. Their useful new drugs are patented, protecting them from competition and allowing them to charge high prices. When the patent ends, other companies are allowed to supply the previously patented drug. These are known as generics. The prices of generic drugs are much lower than the prices of in-patent drugs – it has been suggested that for widely used drugs price falls can be as much as 95%.

    Pharmaceutical companies want to get their new products listed on the Pharmaceutical Benefits Scheme (PBS), because they will sell in much higher volumes. Taxpayers have an interest in ensuring that these drugs move from the high in-patent price to the much lower off-patent price as early as possible.

    On average, a patent provides effective protection from competition for about 14 years. But, of course, companies like monopolies and would like to extend the patent period. Over the past few decades they have used a process known as evergreening to keep generic companies out of the market for longer.

    How evergreening works

    Evergreening is achieved by seeking extra patents on variations of the original drug – new forms of release, new dosages, new combinations or variations, or new forms. Big pharma refers to this as “lifecycle management”. Even if the patent is dubious, the company can earn more from the higher prices than it pays in legal fees to keep the dubious patent alive.

    Evergreening is possible because in Australia the standard required to get a patent is very low. Different methods of delivering drugs (such as extended release, for example) have been known for decades. But when one of these known delivery methods is combined with a known drug, the patent office considers this sufficiently inventive to grant a new 20-year patent. Another favourite evergreening strategy is to patent a slight variation of the drug.

    Brand pharmaceutical companies argue that these “lifecycle management” patents provide improved health outcomes to the community. They meet the (very low) patentability thresholds of novelty and inventiveness. Critics argue that the claimed improved health outcomes are small or non-existent.

    An evergreening story: from Efexor to Efexor-XR to Pristiq

    An example is useful. In the case of the depression drug venlafaxine (marketed as Efexor), the original version had major side-effects. However, when provided in extended release form these side-effects were substantially reduced.

    Naturally the extended release form (Efexor-XR) became preferred. Although it might seem obvious to combine venlafaxine with an extended release form to overcome the side-effect problem, the patent office granted two new patents for extended release versions of venlafaxine.

    One of these was written in such a broad form that it delayed generic entry by two and a half years, while legal wrangling took place. Eventually the evergreening patent was declared invalid. But the cost to taxpayers of this delay is estimated at $209 million.

    Pfizer has a second evergreening strategy for venlafaxine. When venlafaxine is taken, the human body converts it to desvenlafaxine. In other words desvenlafaxine is a variant of the original active pharmaceutical ingredient venlafaxine. Clearly the two compounds are closely related. So it is astonishing that desvenlafaxine passed the tests for getting a patent.

    Desvenlafaxine is marketed as Pristiq. Pristiq entered the market early in the two-and-a-half-year period of legal wrangling over the extended release venlafaxine (Efexor-XR) patent. Pfizer’s marketing of Pristiq in February 2009 was so lavish that it attracted the attention of investigative journalists.

    Pristiq has no additional benefits for patients. Despite this, during the first six months of 2014 half of prescriptions were written for Pristiq rather than for the clinically identical Efexor-XR.

    But Pristiq costs between $A22.32 and $A26.50 more than Efexor-XR, depending on the dose. Based on reported prescription volumes in 2013-14, the cost to the taxpayer of doctors prescribing Pristiq rather than Efexor-XR exceeds $21 million a year.

    Unless generic companies challenge the desvenlafaxine patent, there will be no generic versions of Pristiq until after August 2023, when the patent expires.

    Would you like a placebo with that?

    When such minor variations in drugs are patented and marketed, there are also ethical considerations. Pfizer had to undertake clinical trials to obtain marketing approval for Pristiq. These involved blind comparisons with placebos. Thousands of seriously depressed patients involved in these trials received placebos for no good reason, since the chemical compound was identical with the action of venlafaxine in the body.

    Marketing of Pristiq clearly offers few benefits to the public. It does, however, offer Pfizer the benefit of extracting additional income whenever a doctor prescribes Pristiq. Many patients suffering severe depression were subjected to a placebo in order for Pfizer to undertake the clinical trials needed to obtain marketing approval for Pristiq. There seems to be no system for protecting patients from clinical trials undertaken only to support drugs based on evergreening patents.

    Evergreening entails large-scale economic and social costs for Australians. Reform of our patent laws to prevent evergreening is long overdue. This should be a priority for any government interested in reducing unnecessary costs to the health system.

    But instead, the Trans Pacific Partnership Agreement talks expected to take place in Beijing this weekend could reinforce these problems and make reform of the patent system more difficult.

    Hazel Moir is Adjunct Associate Professor, economics of patents, copyright and other “IP” at Australian National University.  Deb orah Gleeson is Lecturer in Public Health at La Trobe University. This article first appeared in ‘The Conversation’ on 6 November 2014.

  • Helena Britt. General Practice and value for money.

    Last year taxpayers spent A$6.3 billion on GP services through Medicare, about 6% of the total government health expenditure. This was a 50% increase (A$2.1 billion) in today’s dollars over the past decade and equates to about A$60 more per person in real terms.

    Health Minister Peter Dutton says this growth is “unsustainable”. He plans to introduce a GP co-payment in hope of reducing the number of times Australians visit a GP and to ensure users foot some of the bill.

    But targeting primary care for cost savings could backfire. Research we’re releasing todayshows that while the number of GP visits has increased, the services are cost-effective. If the same services were performed in other areas of the health system, they would cost considerably more.

    Under pressure

    Unsustainable or not, Australia’s health-care system faces a number of challenges, most notably from the rising prevalence of chronic conditions, such as type 2 diabetes, heart disease and cancer. This is due to three major factors.

    1. Australia has an ageing population as our world-class health system keeps us alive longer.
    2. In response to government encouragement through Medicare initiatives, GPs are diagnosing disease earlier and providing preventive interventions for health risk factors and diseases such as hypertension, high cholesterol and type 2 diabetes.
    3. An increasing proportion of Australians are overweight or obese, putting them at risk for chronic conditions.

    Earlier diagnosis means people are living longer with diagnosed disease. The result is exponential growth in required care over their lifetime.

    The search for more cost-effective health care for our population should be applauded. But reducing spending on GP services is not the answer.

    What do we get?

    Our team has been studying general practice activity for over 16 years through the Bettering the Evaluation and Care of Health (BEACH) program. This cross-sectional encounter-based study uses changing random samples of about 1,000 GPs per year, each of whom contribute details of 100 encounters with consenting patients. This provides a representative sample of about 100,000 encounters per year from across the country.

    Results from one of the BEACH books, released today, shed some light on what we got for the $2.1 billion of extra Medicare spending on general practice. In 2013-14 there were 35 million more GP services than ten years earlier, a 36% increase. This included 17 million more attendances by patients aged 65 years and over (a 67% increase).

    Length of GP consultations recorded through BEACH suggest that the average consultation now takes almost one minute more than a decade ago. The result is that GPs spend an extra ten million clinical hours with their patients, a 43% increase.

    The number of problems managed at these consultations has also significantly increased. GPs managed an additional 68 million health problems at these encounters (an increase of 48%), including 24 million more chronic problems.

    Management of these problems involved an additional ten million procedures (a 66% increase) and 12 million clinical treatments, such as counselling, advice and education, than a decade ago.

     

    Clearly, increases in the amount and complexity of GP clinical work are reflected in additional Medicare expenditure. If other medical specialists and/or emergency departments had provided these extra services, they would have cost far more.

    The average cost of a GP visit was A$47 from Medicare, plus a A$5 patient contribution. For a private specialist, the average visit costs Medicare A$82 plus a A$38 patient fee.

    A visit to the emergency department, which is paid by state and territory governments, costs far more. In Western Australia, for example, an emergency department visit in 2011-12 cost A$599 on average.

    More, not less primary care

    International research has repeatedly concluded that investment in primary care is the most cost-effective way to provide population health care. As GP services are far cheaper than other types of medical services, discouraging GP visits by introducing a standard co-payment for most patients would increase costs to governments, now and later.

    It may seem counter-intuitive, but one effective way to contain the cost of Australia’s health care would be to expand the use of GP services.

    One issue not acknowledged in the discussion about health costs is the increasing number of patients with multiple chronic conditions. These patients use more resources and are more likely to have fragmented care due to the number of health professionals involved. GPs play the central role in co-ordinating the management of patients with multiple chronic conditions, reducing costly hospitalisations.

    As the age of government-supported retirement increases, many Australians will have to work until they are 70. This highlights the importance of promoting good health across the lifespan, through a strong focus on primary and secondary prevention and co-ordinated management of chronic conditions.

    In any one year 85% of us visit a GP, but only about 15% of us are admitted to hospital, where a far greater proportion of health funds is spent. GPs supply the bulk of care to the population, so general practice is where our investment should be.

    If we want to strengthen our health-care system and ensure its sustainability into the future, it makes sense to encourage people to use its cheapest and most efficient arm: general practice.

     In addition to Helena Britt, other contributors to this article were:  Christopher Harrison, Clare Bayram, Graeme Miller, Joan Henderson and Julie Gordon. The Article first appeared in ‘The Conversation’ on 11 November 2014.

     

     

  • Michael Keating. The politics of the Medicare co-payment

    The adjustments that Tony Abbott announced to the Medicare co-payment are presumably intended to remove this particular ‘barnacle’.  According to Graham Richardson, that self-styled political expert writing in the Australian, Abbott’s parliamentary colleagues ‘are breathing huge sighs of relief … that the Medicare co-payment has been so restructured that it scarcely exists anymore’. Really? Are they stupid or don’t they and Richardson know the facts?

    The reality is that the $7 co-payment has been abandoned for pensioners, other card-holders and children, but for the rest of us the co-payment is still $5 a visit instead of $7. Furthermore, this difference of $2 has been taken back from the doctors who were previously going to receive this $2 while the government got the remaining $5. According to Abbott’s press release the revenue raised by this latest version of the co-payment will still amount to more than $3 billion, which is not much less than the $3.5 billion shown in the Budget; the difference of $0.5 billion presumably reflecting the loss of revenue from pensioners and children who will now not have to pay this extra charge.

    In my view there is almost no chance of doctors lowering their prices by $5 and thus absorbing it, especially given the government’s intention that the Medicare rebates will be frozen with no indexation until July 2018. Instead, now that the doctors will not get the extra $2 that the government previously thought was justified, why would anyone expect the doctors to take another cut of $5 per visit.  Accordingly the $5 co-payment will almost always be passed onto the patient. Everyone will pay $5 more; about half of us for the first time, and the other half will have another $5 added to their existing co-payment. And with the Medicare rebate frozen it is likely that the extent of bulk billing will fall over time so that the co-payment will effectively increase by more than $5 on average over the next few years.

    While removing the co-payment for pensioners and children has significantly ameliorated the impact of the co-payment on the lowest income groups, this latest change in the co-payment therefore does little for middle Australia.  The majority of people will be $5 worse off instead of $7 worse off and why should they be expected to thank the government for this.

    Nevertheless, it has been argued that the budget has to be fixed and expenditure brought down, and in that context setting a price signal is good policy if we are to make health funding sustainable. The issue then is will the new $5 co-payment be more likely to deter unnecessary visits to the doctor, or is it more likely to deter patients who should see their doctor? In the latter case the co-payment is likely to lead to increased health expenditure where necessary treatment is postponed.

    We cannot be sure of the answer to this critical question whether doctor visits, which might be deterred by the co-payment, are necessary or not. But it is worth noting that around half the people affected by the new co-payment, already face a significant price signal so in their case the risks would seem to be more towards the risk of not seeing a doctor when they should. While for those who will face a co-payment for the first time, it is worth noting that the increasing use of hospital outpatients wards, notwithstanding very long waiting times, seems to suggest that people with tight budgets are mostly not seeing a doctor unless they have a good reason.

    Finally as John Menadue showed in his blog posted on 12 December there are many other better ways to restrain the future growth of expenditures in health care. So what Abbott’s announcement of his revised co-payment demonstrated is that we have yet another example of not very good policy that the voters are again likely to reject – the worst of all possible worlds.

  • John Menadue. The dog’s breakfast in co-payments has got worse.

    The government is trying to dump its co-payment mess on to doctors. If doctors decide not to absorb the reductions in the Medicare rebate, many will pass it on to patients and dramatically reduce bulk billing. What a mess!

    In justification for their ill-considered GP co-payment in the budget, the Minister for Health Peter Dutton and Prime Minister Tony Abbott kept parroting that we need some improved price signal in health in order to make our health system sustainable. But this argument is not valid. We have one of the best and most sustainable health services in the world. The Commonwealth Fund ranks Australia fourth in the world for the quality and efficiency of its health service after UK, Switzerland and Sweden. That is due to Medicare.

    That does not mean however that we don’t need to address some major problems in our health system.

    The main reason for our rising health costs is the ability of powerful health providers to extract monopoly rents from taxpayers and the community. These powerful providers exploit their market position in many ways.

    • The private health insurance industry receives a government subsidy of over $6 billion p.a. and through its actions weakens Medicare’s ability to control costs. Gap insurance has underwritten an enormous increase in specialist fees.Just look also at what has happened to health costs in the US as a result of private health insurance.
    • The AMA insists on fee-for-service for treatment of patients and resists any significant workforce reform, particularly for nurses.
    • The Australian Pharmacy Guild uses its political power to restrict competition.
    • Medicines Australia extracts high wholesale prices for its products.
    • The fragmentation of services between the commonwealth and the states increases costs and misallocates resources in favour of hospitals.

    So far all governments have not been prepared to challenge these vested interests. Instead the present government focuses on ill-considered co-payments  which would disadvantage low income people and discourage people from seeing their GP which results in higher specialist and hospital costs.

    In Australia co-payments contribute over $A24 billion p.a. to our health sector. These co-payments are the third highest as a source of health funding – after Federal and State funding.

    This amount of $24 billion p.a. or 17% of our total health funding is high by world standards. Australians pay a higher proportion of their healthcare costs through co-payments than citizens of most other OECD countries. The Commonwealth Fund has found that when healthcare spending is adjusted for the cost of living in Australia, we pay more in direct co-payments than all other counties surveyed apart from Switzerland and the US. Our annual health co-payments per capita are about $US750 compared with Germany $US600, New Zealand $US330 and the UK $US 310.

    The problem with our co-payments is not that they are low. It is that this whole area of co-payments lacks any rhyme or reason. It is a dog’s breakfast.

    Consider how the percentage of total funding from consumer co-payments varies.

    • Public hospitals 2.5%
    • Private hospitals 11%
    • Medical services 12%
    • PBS medicines 16%
    • Dental services 56%
    • Aids and appliances 69%
    • Non-PBS medicines 92%

    There is a wide variation in the impact of co-payments on people with different illnesses and disabilities. For example  people with conditions that can be largely treated by GPs or within the public hospital system, generally incur lower co-payments than those with conditions that require allied healthcare and over-the-counter medicines. This is the case independently of the length or severity of the illness/disability and its impact on both individuals and society. In fact, people with ongoing chronic conditions often end up receiving lower levels of subsidy for their healthcare than those with one-off or self-limiting conditions. Another result of this ad hoc and uncoordinated approach to co-payments is that some people receive almost all their healthcare free at the point of service, and others, with conditions which may be more serious or longer term, face crippling costs for their treatment. For example, someone receiving emergency surgery for, say, the removal of an appendix in a public hospital, can incur no out-of-pocket costs for their treatment, whereas someone with a long-term genetic condition such as Cystic Fibrosis can incur high ongoing costs. The result is a very inequitable allocation of healthcare resources which has a particularly negative impact on people with chronic conditions.

    This chaotic mess in co-payments is not surprising. These co-payments have been introduced without any coherence and therefore inequities and perverse incentives abound. Some services such as public hospital services are free. Some such as pharmaceutical benefits are capped by the government. Some, such as the co-payment for medical services below the safety net thresholds are open-ended; the public subsidy is fixed, leaving the user to bear an open-ended risk. Some such as the medical safety net provisions are proportional to the price of the service. Some safety nets are set on a family basis, others on an individual basis. Some are on a calendar year basis and others on a financial year basis.

    I addition to sorting out the dog’s breakfast of co-payments to ensure greater fairness and efficiency, it is important that we move away from the fee-for-service system by which doctors are remunerated. This type of remuneration promotes turnstile medicine or what is sometimes called ‘six minute medicine’.  FFS may be appropriate for occasional and episodic care but it is not appropriate for long-term and chronic care. We need a major review of remuneration practices in primary care with more emphasis on capitation and bulk charges for chronic care, to keep people well at minimum cost. The British single-payer system has many advantages. One advantage is as the Economist of May 31 this year put it ‘Doctors in the UK are paid to keep people well, not for every extra thing they do so they don’t make money performing unnecessary tasks and tests’.

    The way we remunerate GP’s is far more important for quality of care and efficiency than fiddling with co-payments.

    Even more important is costly specialist care, not the cost of  GP’s in primary care.

    The whole structure of co-payments needs to be reformed.

    And tackling the power of providers is the most important of all to ensure a sustainable health system. As an example just look at the present ‘debate’ over co-payments. It is dominated by the Government and the health provider, the AMA. The voice of the community is scarcely heard in the land!

     

  • John Menadue. Temporary Protection Visas and the Senate cross-bench.

    I wish that the Rudd, Gillard and Abbott Governments had done things very differently on refugee policies. But faced with the impasse at the present time, I welcome the compromise arrangement which the government has negotiated with the senate cross benches – two senators from the Palmer Group, Nick Xenophon, Ricky Muir, Bob Day and David Leyonhjelm. But like the curate’s egg it is good and bad in parts.

    As a result a negotiated package has been achieved that will enable the government to get the refugee processing system moving again to assess the claims of over 30,000 asylum seekers who are in detention or in the community with very restricted rights. The package includes

    • The introduction of Temporary Protection Visas (TPVs) which will grant three year residency for those found to have a legitimate refugee claim. At the end of that period they will not be guaranteed a permanent visa, but may re apply.
    • The introduction of Safe Haven Enterprise Visas (SHEVs) for five years if the asylum seeker spends that time either working or studying in a designated regional area whilst their claim is being processed.
    • There will be an increase in the humanitarian intake of 7,500 places over several years.
    • Asylum seekers on bridging visas will have the right to work.
    • All children in detention, except those on Nauru, will be released into the community.
    • Medicare will be made more readily available.

    This cannot be the end of the process, but I have no doubt that worthwhile progress has been made. The blockage in the system has been removed and processing will start. This is very important.

    It will be important to hold the government to account for this increase in the humanitarian intake to ensure ‘changed circumstances ‘does not result in a failure to implement the increase.

    In the past I have opposed TPVs for maritime arrivals because they leave the claimants in limbo about their future, they denied family reunion and did not deter asylum seekers as successive governments have suggested. But with 30,000 people already in limbo, some progress through TPVs would materially help their position. In a different political landscape, both in Australia and in countries from which asylum seekers have fled, it is not unreasonable to expect that over 80% of asylum seekers issued with TPVs will become permanent residents or citizens within the next ten years.

    Even with rights to work and some Medicare support, the large number of asylum seekers who will be moving into the community will present a major challenge for NGOs, churches and asylum seeker centres who generously support asylum seekers in their need. The government will need to urgently address this financial burden.

    There are other significant problems which will have to be addressed; the increased powers for defence and customs personnel; refoulment; compatibility with the Refugee Convention and judicial oversight.

    To cover its own failure, the ALP has said that the government was using children in detention as pawns in the negotiations. I understand that view and it is true that the government could have released these children at any time as also the last ALP government could have but didn’t.  But as part of a package the release of children is an excellent outcome, whatever the antecedents or background.

    The purists will not like this package. As a friend of mine said, he would not want to have these purists advocating on his behalf. ‘If I were starving, I expect I would die because these purists would deny me access to bread and water while fighting for my entitlement to a three-course meal’.

    I am surprised that the ALP didn’t take the opportunity to negotiate hard over the package. Instead it ceded asylum policy negotiations to the senate cross benches. What a sad abrogation of responsibility by the ALP to leave the outcome to Ricky Muir and others.

    I have written before about the abject failure of the Greens on both climate policy and refugees. On climate policy the Greens voted with the coalition in the Senate in 2009 to vote down Kevin Rudd’s Climate Pollution Reduction Scheme. Always the purists, the Greens wanted more than was on the table. Legislation was defeated in the Senate and we have gone backwards on climate policy ever since. The policy purity of the Greens and their incessant posturing has caused great damage to Australia on climate change.

    And the same is true on asylum seekers and refugees. Here again the Greens sided with the coalition in theSenate over two years ago to vote down theArrangement with Malaysia which the UNHCR said it could work with. The failure of the Senate to pass the enabling legislation after the High Court decision in 2011 meant that the Malaysian Arrangement failed. That triggered the enormous increase in boat arrivals in 2013. This led to Manus and Nauru. For this the Greens must bear a heavy responsibility. But they still continue to wash their hands of responsibility and parade their policy purity. Their posturing has delivered awful consequences for asylum seekers and refugees.

    It is also time both the ALP and the Greens showed some tactical nous. For the present, they have dealt themselves out of effective participation and negotiation on a very difficult but critical issue – the plight of 30,000 asylum seekers whose claims are waiting assessment.

    These amendments to the Migration Act must be seen as work in progress. There are many important issues that will hopefully be corrected with a change of government. There many important things that need to be done

    • Increase the humanitarian intake to at least 25 000 pa
    • Abolish mandatory detention which is cruel, expensive and does not deter.
    • Establish Orderly Departure Arrangements with Sri Lanka, Iraq and Afghanistan
    • Open more migration pathways, like 457 visas for persons who may be borderline refugees
    • De militarise our refugee policies and programs.

    A lot more must be done. But breaking the deadlock on the 30,000 forgotten people in detention or on bridging visas is an important step.

    As refugee advocates we have some hard thinking ahead.  To date we have failed comprehensively   to win improvements for people in great need. The perfect has become the enemy of the good. Needy asylum seekers are the losers.

    Sometimes harm minimisation is the best course, a course that the ALP and the Greens chose not to take on the Migration Act amendments.

    Aren’t 30,000 strangers in our land in need of help today, not in one or two years’ time!